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Resumo 
O espermatozoide caracteriza-se por duas partes fundamentais, a cabeça e a 
cauda (flagelo). O axonema (Ax) é o motor do movimento dos espermatozoides e 
estende-se por todo o comprimento do flagelo. Este é composto por 9 pares de 
microtúbulos periféricos um interno (A) e um externo (B) (dupletos), unidos entre si 
através de pontes de nexina, e ligados a um par de microtúbulos centrais, por 
projeções radiais medianas. Os microtúbulos A têm 2 braços de dineína, um exterior 
e outro interior. Ao conjunto dos microtúbulos centrais, da ponte fibrilar que os une e 
da bainha fibrilar que os rodeia, denomina-se complexo do par central (CPC). O CPC 
funciona como distribuidor de sinal para a motilidade, distribuindo o sinal para as 
projeções radiais, que, com o auxílio de um complexo designado complexo regulador 
das dineínas (DRC), transmitem sinais regulatórios e ativam seletivamente os braços 
de dineína. Estes convertem, através de ATPases, a energia química contida no ATP 
em energia mecânica, que originará o movimento dos espermatozoides. As fibras 
densas externas e a bainha fibrosa são duas estruturas que rodeiam o Ax. A bainha 
fibrosa é uma importante estrutura que influência/modela a flexão e o movimento 
flagelar, e contém enzimas glicolíticas que fornecem energia necessária à motilidade 
A infertilidade é uma doença que afeta cerca de 10-17% dos casais, sendo 
uma patologia no elemento masculino, responsável por cerca de 30-45% dos casos. 
A imotilidade dos espermatozoides destaca-se como uma das principais causas de 
infertilidade masculina. A base genética e os mecanismos moleculares que controlam 
a motilidade do flagelo dos espermatozoides não são completamente compreendidos. 
A discinesia ciliar primária (PCD) e a displasia da bainha fibrosa (DFS) são 
consideradas as principais síndromes associadas à imotilidade dos espermatozoides. 
PCD é uma doença autossómica recessiva, em que a maioria dos pacientes é infértil 
devido a imotilidade provocada por anomalias no Ax. A síndrome de Kartagener (KS), 
caracterizada por situs inversus, sinusite crónica e bronquiectasias, ocorre em 50% 
dos casos de PCD. A DFS é outra doença maioritariamente caracterizada por 
hiperplasia e desorganização da bainha fibrosa. Vários genes foram associados a 
estas síndromes e à formação e função do flagelo. 
Os espermatozoides totalmente imóveis de cinco doentes portugueses com 
astenozoospermia foram previamente analisados por microscopia eletrónica de 
transmissão. Nessa análise, foram identificados 4 pacientes compatíveis com a 
síndrome DFS associados a anomalias na bainha fibrosa, no CPC, projeções radiais, 
e braços de dineína; e um paciente com situs inversus em que foi detetada ausência 
dos braços de dineína e pontes de nexina (compatível com a KS). Assim, o objetivo 
   
 
 
 
deste trabalho foi identificar uma causa genética para os fenótipos dos pacientes 
anteriormente analisados. Para tal, começamos por investigar na literatura genes 
envolvidos na DFS e PCD bem como associados às estruturas flagelares em que 
foram encontradas anomalias nos nossos pacientes. Foram selecionados sete genes: 
CCDC39 e CCDC40 (braços internos de dineína e o DRC), DNAH5 e DNAI1 (braços 
externos de dineína), RSPH1 (projeções radiais e CPC), AKAP3 e AKAP4 (bainha fibrosa). 
Foram desenhados oligonucleotídeos iniciadores para as regiões exónicas (e 
fronteiras intrónicas) de cada gene. Seguidamente, essas regiões foram amplificadas 
pela reação em cadeia da polimerase (PCR) e sequenciadas pelo método de Sanger. 
Adicionalmente, foi realizada a sequenciação de todas as regiões exónicas do 
genoma (exoma) usando sequenciação de nova geração (NGS) no paciente com 
situs inversus. 
Com este trabalho, identificamos 9 novas variantes de sequência (CCDC39: 
c.2540A>G, CCDC40:c.2620-92C>T, CCDC103:c.104G>C, DNAH5:c. 5882+133A>G e 
c.11570+124G>A, DNAH6:c.3167A>T, GAS8:c.828C>G, INSL6:c.262_263delCC e 
SPAG17:c.4445G>T); e 10 variantes raras (CCDC39:c.233G>A; CCDC40:c.2682G>A; 
DNAH5:c.1537-102T>A, c.1537-100_1537del-99delTT, c.3835-3delT, c.7408-84_7408-
83delAT , c.10282-81delT, c.10872+84T>C; DNAH10:c.7895C>T e DNAI1:c.81+61A>G). As 
variantes nos genes CCDC103 e INSL6 são as mais promissoras a estarem 
relacionadas com a imotilidade.  
O nosso trabalho demonstrou a heterogeneidade e a complexidade genética 
da DFS, PCD e da motilidade dos espermatozoides. Destacamos as dificuldades em 
investigar as causas genéticas da imotilidade usando a sequenciação convencional 
de Sanger, nomeadamente devido à morosidade e custos associados. Também 
evidenciamos a importância da aplicação da NGS para investigação de doenças 
geneticamente complexas e para compreender a base genética dos processos 
altamente complexos como a formação do flagelo de espermatozoides e a motilidade. 
Com este trabalho pretendeu-se iniciar o diagnóstico genético dos pacientes 
com imotilidade total dos espermatozoides, bem como ajudar a encontrar potenciais 
marcadores genéticos para os indivíduos com este tipo de patologia.  
Para investigação futura, identificar quais são os genes (e variantes) que estão 
envolvidos neste tipo de patologias, como se relacionam, bem como, entender de que 
modo as alterações detetadas poderão afetar a função da proteína, são aspetos 
essenciais para planear e desenvolver futuras terapias, como a terapia genética. 
Palavras-chave: Displasia da bainha fibrosa; Sequenciação do exoma; 
Sequenciação de nova geração; Sequenciação de Sanger; Síndrome de Kartagener; 
mobilidade dos espermatozoides.   
  
Abstract 
The spermatozoon is divided into two fundamental parts, the head and the tail 
(flagellum). The axoneme (Ax) is the flagellar motor of the sperm cell and extends 
throughout the flagellum. The Ax is composed by 9 peripheral doublets of 
microtubules (an internal (A) and an external (B)), linked to each other by nexin 
bridges, and connected by radial spokes (RS) to a single pair of central microtubules. 
The microtubule A has two dynein arms (DA), outer (ODA) and inner (IDA). The 
central microtubules are linked by a fibrilar bridge and are surrounded by a fibrilar 
central sheath, constituting the central pair complex (CPC). The CPC functions like a 
distributor of motility signal. The CPC gets the signal and distributes to the RS that, 
allied with the dynein regulatory complex (DRC), transmit regulatory signals that 
selectively activate the DA. DA converts the chemical energy contained in ATP, 
through ATPase, into the mechanical energy which will allow the flagellar movement. . 
The outer dense fibre and the fibre sheath (FS) surround the Ax. The FS 
influences/modulates the bending and the flagellar beat and provides energy for 
motility. In addition, it contains glycolytic enzymes that provides energy for motility.  
Infertility is a current significant problem that affects about 10-17% of couples 
worldwide. A male contribution to infertility is found in 30–45% of the cases. There are 
several causes for male infertility being the sperm immotility one of the major. The 
genetic basis and molecular mechanisms that control sperm motility are not fully 
understood. Primary ciliary dyskinesia (PCD) and dysplasia of the fibrous sheath 
(DFS) are considered the two main disorders associated with sperm immotility. PCD 
is an autosomal recessive disease causing male infertility due to sperm immotility 
associated to abnormalities in the Ax. Kartagener syndrome (KS), characterized by a 
combination of situs inversus, chronic sinusitis, and bronchiectasis, occurs in about 
50% of PCD patients. DFS is a disease mostly characterized by hyperplasia and 
disorganization of the FS. Several genes have been described as associated to these 
syndromes and to the assembly and function of the normal sperm flagellum. 
The total immotile spermatozoa of five Portuguese patients with 
asthenozoospermia were previously analysed by transmission electron microscopy. 
This ultrastructural analysis revealed 4 cases with DFS associated with disrupted 
CPC, RS, DA and doublets; and one patient with situs inversus who presented 
absence of DA and nexin bridges (compatible with KS). Therefore, the objective of the 
present work was to identify genetic alterations that could explain patients’ 
phenotypes. In that way, we searched for genes associated to DFS and PCD, as well 
   
 
 
 
as, with the ultrastructural defects in sperm cells of these patients. Seven genes were 
initially selected for analysis: CCDC39 and CCDC40 (DRC and IDA), DNAH5 and 
DNAI1 (ODA), RSPH1 (RS), AKAP3 and AKAP4 (FS). We designed primers for the 
exonic regions (plus intronic boundaries) of each gene. Then, these regions were 
amplified by polymerase chain reaction (PCR) and sequenced by Sanger’s method. 
Additionally, we sequenced all the exonic regions of the genome (exome) in the 
patient with situs inversus using next-generation sequencing (NGS) technology. 
As result, we identified 9 new DNA sequence variants (CCDC39:c.2540A>G, 
CCDC40:c.2620-92C>T, CCDC103:c.104G>C, DNAH5:c. 5882+133A>G e c.11570+124G>A, 
DNAH6:c.3167A>T, GAS8:c.828C>G, INSL6:c.262_263delCC e SPAG17:c.4445G>T); and 
10 rare variants (CCDC39:c.233G>A; CCDC40:c.2682G>A; DNAH5:c.1537-102T>A, 
c.1537-100_1537-99delTT, c.3835-3delT, c.7408-84_7408-83delAT, c.10282-81delT, 
c.10872+84T>C; DNAH10:c.7895C>T e DNAI1:c.81+61A>G). The variants in CCDC103 
and INSL6 are the most promising to have a role in sperm immotility.   
Our work demonstrates the genetic heterogeneity and complexity of DFS, PCD 
and sperm immotility. We highlight the difficulties for the identification of the genetic 
causes using conventional (Sanger) sequencing, especially due to the labour and 
costs involved. We also demonstrate the importance of exome sequencing, as broad 
mutation screening method, very useful to understand the genetics of highly complex 
processes as formation/assembly of sperm flagellum and sperm motility. With these 
work we intended to initiate the genetic diagnosis of this patients, and help to identify 
potential genetic markers for individuals with this kind of pathology.  
Understanding which genes are involved in sperm motility, how they are 
correlated as well as the exactly protein’s function and how these variants may affect 
its function, is essential to plan and develop, in the future, a gene therapy. 
 
 
 
 
 
Key words: Dysplasia of the fibre sheath (FSD); next-generation sequencing; 
Genetic diagnosis; Kartagener syndrome; Sanger sequencing; Sperm immotility 
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INTRODUCTION 
1. SPERM: A LITTLE OF HISTORY 
 
In 1677, the scientist Antonie van Leeuwenhoek (1632-1723), a great scientist 
known as the father of microbiology, with hand-made lenses and microscopes, first 
observed the spermatozoa and called them ‘‘animalacula’’. The word spermatozoa 
was invented, years later, by Karl von Baër (1792-1876), who established the new 
science of comparative embryology alongside with comparative anatomy (Magner, 
2002). Spermatozoon (sperm; plural spermatozoa) has origin from the Greek word 
“sperein” which means “to sow”. This is because it was assumed that the semen was 
the crucial factor for sexual reproduction and that females merely provided “the fertile 
garden in which the male seed would flourish and grow” (citing Birkhead and 
Montgomerie, 2008). However, the really function of the sperm remained uncertain 
and controversial. Leeuwenhoek speculated that the “animalcules” were able to 
penetrate the egg and fertilize it. Oppositely, some of his colleagues argue that these 
“animalcules” were just parasites, and believed that were present in vast number, in 
excess of what was necessary to fertilize an egg (Birkhead and Montgomerie, 2008). 
The roles of spermatozoa begun to be clarified from 1780s, when the scientist 
Lazzaro Spallanzani (1729–1799), using amphibians, showed that the contact 
between egg and semen is essential for the development of a new animal, ending 
with the theory of “aura spermatica” that stated that the development of the egg would 
be due to a sort of vapor emanating from the sperm. However, Spallanzani failed to 
prove the specific role of the sperm. Years later, using dogs, the first artificial 
insemination was performed, and the roles of the sperm and of the oocyte in sexual 
reproduction began to be understood (Capanna, 1999). Albert von Kölliker (1817-
1905), was one of the first to interpret tissue structure in terms of cellular elements 
and to conclude that the semen off all animals contains sperm and determine that 
spermatozoa develop from cells residing in the testes. Franz von Leydig (1821-1908) 
described the microscopic characteristics of the testicular cells, that nowadays are 
called Leyding cells and posteriorly, Enrico Sertoli (1842-1910), in 1865 described the 
Sertoli cells (Christensen, 2007; Staff, 2009). 
The history teach us that all advances about structure and function of the 
sperm walked, walks and will be walking side by side with the development of 
microscopy and technologies. As we are in the age of high-tech breakthroughs, 
progressions will be made and consequently many advances on the scientific 
knowledge about sperm will be certainly obtained.  
2 
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2. THE SPERM BIOGENESIS: SPERMATOGENESIS 
 
Spermatogenesis is the biological process that forms the spermatozoa and 
takes place within seminiferous tubule boundaries of the testis. The epithelium of the 
seminiferous tubule consists of germ cells that form numerous concentric layers 
penetrated by Sertoli cells, whose one of the functions is to nourish the germ cells and 
maintain their cellular associations throughout the process of spermatogenesis, which 
lasts approximately 64 days (Hess and de Franca, 2008). 
At birth, in the seminiferous tubules, A-dark spermatogonia (originated during 
the fetal life from primordial germ cells) remain mitotically inactive until the peri-
pubertal period. At the pubertal period the production of gonadotropic hormones 
induces the mitotic proliferation of A-dark spermatogonia, originating A-pale 
spermatogonia. After the pubertal period and through a massive mitosis they will allow 
the continuous production of spermatozoa all over the reproductive male lifespan. 
This phase is known as proliferative phase. After puberty, A-pale spermatogonia 
differentiate into B-type spermatogonia, which then enter meiosis and give rise to 
preleptotene, leptotene, zygotene and pachitene primary spermatocytes. Then, the 
first meiotic division occurs and originates two secondary spermatocytes. Each 
experiences the second meiotic division and give rise to four round spermatids. This is 
designated meiotic phase (De Kretser, 1998; Sutovsky and Manandhar, 2006). Due to 
the unique architecture of the seminiferous epithelium, the sequence of germ cells 
types in the seminiferous epithelium is established in a stepwise manner. 
Consequently, Sertoli cells, A-dark and A-pale spermatogonia are found in newborn 
and children, while spermatocytes and spermatids appear in the adult testis. 
Temporarily, the proliferative and meiotic phase of spermatogenesis can be 
synchronized or can be sequential. Relatively to the localization, the proliferative 
phase occurs in the nutrient rich basal compartment, while the meiotic phase takes 
place within the adluminal compartment, where cells are protected by the blood-testis 
barrier (Hess and de Franca, 2008). 
In the last part of spermatogenesis, round spermatids undergo marked 
morphological changes, but no further cell divisions occur. This stage can be divided 
into spermiogenesis and spermiation. Spermiogenesis consists of three main steps:  
(i) nuclear condensation and movement of the nucleus to the periphery of the cell; (ii) 
formation the acrosome, which becomes attached to the surface of the nucleus; and 
(iii) flagellar formation. These proceeds through 4 steps: Golgi, capping, acrosomal 
and maturation (De Kretser, 1998; Sutovsky and Manandhar, 2006).  
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During the Golgi phase, the membrane of the acrosomal vesicle (AV), that 
begins its formation in the pachytene stage, is attached to the nuclear envelope and 
grows due to the constant influx and fusion of Golgi derived vesicles (Abou-Haila and 
Tulsiani, 2000). The centrioles, located near to Golgi, are translocated to the pole 
opposite to the developing acrosome, establishing the polarity of the cell. The distal 
centriole participates in formation of the axonema (Ax) and the flagellum, while the 
proximal centriole (PC) will ultimately give rise to the neck piece (NP). The Golgi 
phase also involves the development of the midpiece (MP), where the mitochondria, 
which were previously located around the nucleolus, start to didperse close to 
periphery of the cell and close to plasma membrane (Gupta, 2006). The distal 
centriole disappears in spermiogenesis, meaning that sperm cells only contain one 
centriole, the PC.   
In the Cap phase, the nucleus, the AV and the body of the spermatids become 
elongated, and chromatin begins to condensate. The Golgi apparatus continues to 
produce and deliver the proteins and membranes needed for enlargement and 
differentiation of the AV (Abou-Haila and Tulsiani, 2000; Moreno et al., 2000).  
In the acrosomal phase, the nucleus becomes further condensed and 
elongated as well as the AV and the cell. The mitochondria migrate to the 
surroundings of the developing flagellum and arranged into a helix that terminates at 
the annulus (An). During this phase, occurs the formation of outer dense fibres (ODF) 
associated with the Ax and fibrous sheath (FS), thus completing the formation of the 
tail and the developing spermatozoa orient themselves in a way that their tails point 
towards the centre of the lumen, away from the epithelium (Gupta, 2006).  
In the maturation phase, is when occurs the extrusion of the rest of the 
cytoplasm (the residual body). 
During spermiogenesis, histones are remove and replaced by transition 
proteins and these by protamines (Meistrich et al., 2003). Also, the majority of the 
mitochondria are removed and just a few are maintained in the MP (Piomboni et al., 
2012). After spermiogenesis, it occurs the spermiation, which consists in the release 
of the fully differentiated testicular spermatozoa into the lumen of the seminiferous 
tubules to travel through to the rete testis to the epididymis. Release is attained by 
disappearance of cell junctions between Sertoli cells and spermatozoa and retraction 
of the cytoplasm of Sertoli cells. Once released the spermatozoa, Sertoli cells 
phagocyte the remainder of the residual bodies. This process is complex and can be 
particularly affected by hormonal modifications, temperature changes and toxins 
(Donnell et al., 2011).  
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Spermatogenesis (resumed on the scheme of the Fig. 1) is a remarkable 
process that involves multiple factors, such as endocrine, autocrine and juxtacrine, 
paracrine. About 100 genes have been found by genetic engineering to be implicated 
in spermatogenesis (Escalier, 2001). It is maintained by the secretion of the 
hypothalamic gonadotropin releasing hormone (GnRH) that stimulates the secretion of 
follicle stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary 
gland. LH is responsible for stimulating the secretion of testosterone by Leydig cells 
located in the testicular stroma, whereas FSH and testosterone act over Sertoli cells, 
which are essential, among other important roles, to nourish the developing sperm 
cells (Holdcraft and Braun, 2004; Chocu et al., 2012).   
 
Figure 1. I. Representation of the basic steps that occur in male germ cells during spermatogenesis.  
At birth, in the seminiferous tubules, A-dark spermatogonia (Ad), originated from primordial germ cells (PGC), 
remain mitotically inactive until the peri-pubertal period. In pubertal period the production of gonadotropic 
hormones induces the mitotic proliferation of A-dark spermatogonia, originating A-pale spermatogonia (Ap), 
which after the pubertal period, will allow the continuous production of spermatozoa (this is the proliferative 
phase). A-pale spermatogonia will differentiate into B-type (B), that will enter meiosis and give rise to primary 
spermatocytes (pink circles). These cells will undergo the first meiotic division of spermatogenesis to originate 
two secondary spermatocytes (green circles) and each experiences the second meiotic division and give rise to 
four round spermatids (purple circles). This is designated meiotic phase. The round spermatids undergo marked 
morphological changes (spermiogenesis) to form the mature spermatozoa, which are released from Sertoli cells 
into the lumen of the seminiferous tubule (spermiation). 
II. Schematic drawing of the seminiferous tubule illustrating the morphological features of germ cells 
development. The proliferative phase occurs in the nutrient rich basal compartment, while the meiotic phase 
takes place within the adluminal compartment, where cells are protected by the blood-testis barrier.  
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3. THE SPERM STRUCTURE 
 
In this section we will make an introduction about the complex and remarkable 
structure of the sperm cell, with more emphasis to the components involved in sperm 
motility.   
The spermatozoon (Fig. 2 and 3) is divided into two fundamental parts, the 
sperm head and the sperm tail or flagellum. The head is divided in acrosomal and 
postacrosomal regions and contains the genetic 
material in the nucleus and important enzymes 
for fertilization in the acrosomal vesicle (AV).  
The sperm flagellum is responsible for 
sperm motility, and is divided into four major 
regions, the neck piece (NP), the midpiece 
(MP), the principal piece (PP) and the end 
piece (EP). The spermatozoon is surrounded by 
a plasma membrane. 
Figure 2 Spermatozoa seen in phase contrast microscopy. Head (H), with acrosomal vesicle (AV) and nucleus 
(N). Flagellum (F), with midpiece (MP) enlarged to contain the mitochondrial sheath.  
Image provided by Professor Mário Sousa. 
 
 
 
Figure 3. Schematic drawing of a human spermatozoon. The spermatozoon is morphologically divided into two 
parts: the head and the flagellum. The head is composed by: plasma membrane (PM; that surrounds all sperm cell); 
acrosomal vesicle (AV); nucleus (N); postacrosomal region (PAR), which connects the head to the neck piece (NP); 
and by a posterior ring (PR). The sperm flagellum is divided into four major regions, the NP, the midpiece (MP), the 
principal piece (PP) and the end piece (EP). The MP includes: the proximal centriole (PC), segmented columns (SC), 
outer dense fibers (ODF), axoneme (Ax, which extends for all flagellum) and mitochondrial sheath (M). The proximal 
PP starts immediately after the annulus (An) and contains the Ax, the ODF and the rings of fibrous sheath (FS). In the 
distal PP are only observed the Ax and FS, and the EP only contains the Ax. 
Image provided by Professor Mário Sousa.   
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3.1. Sperm plasma membrane  
The sperm plasma membrane is a continuous cell boundary and its function 
consists in maintaining cell integrity and form a dynamic interface between the cell 
and environment. It has a characteristic subdivision into regional domains that differ in 
physical, chemical and antigenic properties; in the architectural organization, in the 
glycoproteins and other components; as well in its function. These domains are 
dynamic and undergo changes in organization and composition during maturation, 
capacitation, oocyte-sperm interaction and fusion (Toshimori, 1998; Flesch and 
Gadella, 2000).  
The sperm head plasma membrane is separated from the plasma membrane 
of the MP by the posterior ring (PR). The membrane of the MP is separated from the 
plasma membrane of the PP by an annular ring: the annulus (An). Membrane 
domains not presenting any physical barrier also show limits restricting the mobility of 
components or restrict certain antigens, which are maintained by a regional 
specialization of cytoskeletal elements. For instance, the cytoskeletal proteins actin 
and spectrin are localized in acrosomal region (AR) and PP, whereas vimentin is 
restricted to the ER (Grudzinskas and Yovich, 1995).  
3.2. Sperm Head Structure 
The main components of the sperm head are the nucleus and the AV. The 
head (Fig. 4) is surrounded by the plasma membrane and is morphologically divided 
into two regions: acrosomal (AR) and postacrosomal (PAR). The AR is further divided 
into anterior acrosomal region (AAR) and equatorial region (ER). The PAR starts in 
the ER and ends in the PR and is devoid of the AV coat and is filled with numerous 
proteins and filaments involved in sperm-egg 
interaction and activation (Toshimori and Ito, 2003). 
According to the World Health Organization 
(WHO) (WHO, 2010), a “normal” sperm head has 
about 4.5 µm in length and 3 µm in diameter. It is 
smooth and generally oval in shape. However, 
spermatozoa are pleomorphic it is likely that the 
range of normal sperm both in fertile and infertile 
men is about 30%.  
 
Figure 4. Ultrastructure of the sperm head. Images from Transmission Electron Microscopy (TEM).  
The sperm head is surrounded by the plasma membrane (PM) and is divided into the acrosomal region (AR) and 
postacrosomal region (PAR). The AR is further divided into anterior acrosomal region (AAR) and equatorial region 
(ER). The head contains the acrosomal vesicle (AV), with the outer (O) and inner (I) acrosomal membranes; and the 
nucleus (N). The posterior ring (arrowhead) is the frontier between head and flagellum. Components of the flagellum: 
proximal centriole (PC), the basal plate (BP) and the segmented columns (SC). 
Image provided by Professor Mário Sousa. 
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3.2.1.  The acrosome 
The acrosome is an organelle that develops over the anterior half of the sperm 
head, and comprises 40–70% of the head area. In this region, the nucleus presents a 
reduced number of small pale areas (“vacuoles”) that are uncondensed nuclear 
regions containing the rRNA genes and other genes that are first transcribed after 
gamete fusion (Grudzinskas and Yovich, 1995).  
The acrosomal membrane has two membranes: the inner and outer. The inner 
acrosomal membrane covers the nuclear envelope and is highly stable, while the 
outer acrosomal membrane is unstable and easily disrupted. These differences reflect 
their respective roles in cumulus penetration and in zona pellucida binding and 
penetration. The acrosomal matrix is composed by a number of different hydrolytic 
enzymes and other proteins, which are necessary to penetrate the zona pellucida. 
The AV differs from others organelles derived from Golgi apparatus, such lysosomes, 
since is a secretory vesicle and contains specific enzymes like proacrosin. Proacrosin 
and hyaluronidase are the most important and the best characterized enzymes of the 
AV (Grudzinskas and Yovich, 1995; Abou-Haila and Tulsiani, 2000). Acrosin is 
present only in spermatogenic cells and it is synthesized as a proenzyme (the 
proacrosin), which after the acrosome reaction is activated to the mature enzyme 
(Zahn et al., 2002). This enzyme has a vital role in fertilization due to its capability to 
hydrolyze the zona pellucida of the oocyte (Yamagata et al., 1998) and participation in 
sperm-zona pellucida interaction (Howes and Jones, 2002; Mao and Yang, 2013). 
The absence of proacrosin or reduced activity of acrosin may be related with infertility 
(De Jonge et al., 1993; Adham et al., 1997). 
3.2.2.  Perinuclear material 
The perinuclear material (also called perinuclear theca) is a cytoskeleton 
element that covers the apical and lateral part of the mature sperm nucleus. It has a 
volume practically insignificant but is important to keep the AV attached to the nucleus 
and is involved in sperm–oocyte interaction and oocyte activation. Moreover, it 
harbors a complex of signalling proteins collectively referred to as sperm oocyte 
activating factors that after gamete fusion are dispersed across the ooplasm and 
trigger the signalling pathways, which lead to oocyte activation, polyspermy block and 
initiation of zygotic development (Mújica et al., 2003; Sutovsky et al., 2003; Oko and 
Sutovsky, 2009). 
 
8 
FCUP 
Mutation analysis of genes involved in sperm motility: A study on patients with total sperm immotility 
 
 
3.2.3.  Nucleus  
The sperm nucleus contains the genetic material that is completely inactive 
until fertilization (Auger and Dadoune, 1993). The nuclear envelope has no pores in 
the apical, lateral and PAR regions. After the PR, the plasma membrane initiates the 
flagellum. In this region it can be observed redundant nuclear envelope that is rich in 
nuclear pores. In the base of the nucleus lies a region called implantation fossa that is 
covered by a layer of electron dense material forming the basal plate (BP), which links 
the nucleus to the segmented columns (SC) (Pedersen, 1972; Grudzinskas and 
Yovich, 1995). 
The sperm nucleus presents a highly organized and compacted structure, 
consisting of DNA and heterogeneous nucleoproteins. This condensation enables 
sperm to compact their DNA content, protecting it during the transit through the male 
and female genital tracts. The organization and amount of DNA, as well as the 
arrangement and the composition of the nucleoproteins are completely different from 
somatic nuclei (Ward and Coffey, 1991; Fuentes-Mascorro et al., 2000). 
Chromosomes demonstrate a different pattern (with a ‘looped hairpin’ conformation 
orientating centromeres in the direction to nucleus and distal telomeres to periphery) 
designed for favouring the unpacking and activation of the male genome after 
fertilization (Mudrak et al., 2005).  
During spermiogenesis the sperm nucleus undergoes several changes. At the 
round spermatid stage, the round nucleus is transcriptional active and histones are 
the main nuclear proteins. Afterwards, the transcription ceases and histones are 
replaced first by transition proteins (TP) and then by protamines. The TP1 and TP2 
act on DNA supercoiling and reduce the number of DNA breaks, and errors in these 
proteins were associated with male infertility (Meistrich et al., 2003; Zhao et al., 2004). 
The nucleus retains a nucleohistone component (about 15%) (Wykes and Krawetz, 
2003), but protamines are the major nuclear sperm proteins. Important roles have 
been proposed (reviewed by Oliva and Dixon, 1991; Oliva, 2006), as: (1) protection of 
the genetic material from damage; (2) participation in the imprinting of the paternal 
genome during spermatogenesis; (3) condensation of sperm genome, generating a 
more compact and hydrodynamic nucleus. Sperm with most hydrodynamic nucleus 
will move faster, fertilizing the oocyte first. Abnormal sperm protamines concentrations 
were correlated with DNA fragmentation (Aoki et al., 2005); defects of late 
spermiogenesis (Carrell and Liu, 2001) and human male infertility (Aoki et al., 2006; 
Oliva, 2006; Steger et al., 2003). 
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3.3. Sperm Flagellum Structure 
The flagellum (Fig. 5) is responsible for sperm motility and contains both the 
site of energy production and the propulsive apparatus for the cell. To fertilization 
occur, sperm must reach the oocyte and consequently active motility is a crucial 
condition for natural fertilization take place. The sperm only becomes fully motile after 
being exposed to several external and intracellular factors during its storage in the 
epididymis that gives to these cells the ability to exhibit a vigorous motility and 
subsequently undergo a further period of maturation during their ascent of the female 
reproductive tract, which is known as capacitation (Aitken et al., 2007).  
The flagellum is almost totality the length of human sperm, with about 55-66 
μm long (Holstein and Roosen-Runge, 1981). It consists of four distinct segments 
(Fig.3): the NP, the MP, the PP and the EP. The NP contains the BP, the proximal 
centriole (PC) and the SC. The MP contains the Ax, the outer dense fibres (ODF) and 
the mitochondrial sheath that ends at the An. The PP contains the Ax, the ODF 
(proximal PP) and the fibrous sheath (FS: proximal and distal PP). The EP contains 
only the Ax (Grudzinskas and Yovich, 1995).  
 
 
Figure 5. 1-Ultrastructure of sperm neck piece. The posterior ring (PR) makes the connection between the head 
and the neck piece. The neck piece is composed mainly by the segmented columns (SC), the proximal centriole (PC) 
and the basal plate (BP). 
2- Ultrastructure of sperm midpiece (MP) and principal piece (PP), which are separated by annulus (An). The 
axoneme (Ax) in the PP is surrounded by the outer dense fibers (ODF). The MP contains the mitochondrial sheath (M) 
and the PP is distinguished by the presence of a ring of the fibrous sheath (FS). 
Image provided by Professor Mário Sousa.   
 
 
 
BP 
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3.3.1.  Axoneme (Ax) 
The Ax is the flagellar motor of the sperm and therefore knowledge about its 
structures is essential to understand the mechanisms of sperm motility. The Ax (Fig. 
6, 7) is composed by two central microtubules surrounded by nine peripheral 
microtubule doublets, forming the 9+2 microtubules pattern. The Ax begins to be 
formed at spermatogenesis Golgi phase by the microtubule polymerizing activity of 
distal centriole. Subsequently, in the acrosomal phase, the PC attaches to the basal 
nuclear envelope and originates 9 peripheral microtubule doublets (De Krestser, 
1998; Sutovsky and Manandhar, 2006). Each doublet is externally anchored to 9 
corresponding asymmetric ODF in MP and proximal PP. The Ax is also surrounded by 
mitochondria in the MP and by the FS in PP (Afzelius et al., 1995; Inaba, 2007).  
The nine doublets are numbered 1 to 9 in a clockwise direction with number 1 
being the one situated on the perpendicular plane to the two central microtubules. The 
doublets are linked by nexin links and each consists of an internal complete 
microtubule (A) onto which is attached a second external and incomplete microtubule 
(B). Extending from each microtubule A in the direction of the microtubule B of the 
adjacent doublet exist a pair of projections, named dynein arms (DA) due to the major 
component of these arms be the protein dynein. DA are designated by their position 
as either 'inner' or 'outer' (IDA or ODA, respectively) (Grudzinskas and Yovich, 1995). 
The two central microtubules are linked by a series of regularly spaced linkages 
(central projections) and are surrounded by a fibrilar central sheath, which constitute 
the central pair complex (CPC, firstly called central apparatus) of the Ax (Goodenough 
and Heuser, 1985; Afzelius et al., 1995). Microtubule doublets bind to the two central 
microtubules by radial projections, called radial spokes (RS). Between the RS and 
both DA, is localized the dynein regulatory complex (DRC), which is the ideally site to 
mediate signals, either mechanical, enzymatic, or both, between different Ax 
components (Gardner et al., 1994; Heuser et al., 2009). Recent studies, revealed that 
DRC forms a continuous connection from the A-tubule to the B-tubule of the 
microtubule doublet, which aligned to the finding that the DRC is the only structure 
besides the DA that connects with outer doublets suggest that the DRC is the nexin 
link (Heuser et al., 2009).  
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Figure 6. Ultrastructure of the axoneme (Ax). The Ax consists of nine microtubule doublets (1-9) and two central 
microtubules, forming the 9+2 pattern. Each doublet has an inner peripheral (A) and an outer (B) microtubule and 
doublets are linked by nexin bridges (pn: between the A and B adjacent pairs). They are connected to the two central 
microtubules by radial spokes (RS). The microtubule A of each doublet has two dynein arms (white arrowheads). The 
doublet whose radial projection is perpendicular (dash dotted) to the central microtubules is named No. 1, with the 
numbering up to 9 following the clockwise direction. The two central microtubules are joined by the central bridge 
(black arrowhead) and wrapped in a fibrilar sheath (dashed circle). From the neck to the end of the proximal principal 
piece the outer dense fibers (ODF) are adjacent to the Ax and through all principal piece there are rings of the fibrous 
sheath (FS).  
Image provided by Professor Mário Sousa.   
 
3.3.2 Outer dense fibres (ODF) 
The flagellum of the mammalian spermatozoon characteristically possesses 9 
ODF positioned around the Ax (Holstein and Roosen-Runge, 1981; Grudzinskas and 
Yovich, 1995). The ODF are formed during spermiogenesis in acrosomal phase by 
the SC and are located on the outside of the Ax in the MP and proximal PP of the 
sperm tail (De Krestser, 1998; Oko, 1998). Each fibre is composed by a medulla (an 
inner part) that is surrounded by an incomplete cortex (a peripheral area). The 
medulla is highly stable, composed by several cystein-, serine- and proline-rich 
intermediate filament-like proteins with a high degree of zinc-dependent disulfide 
cross-bridging; whereas the cortex is less stable, composed by a single layer of 
globular subunits (Olson and Sammons, 1980; Grudzinskas and Yovich, 1995).  
The ODF have important roles on the flagellum, they provide elasticity 
(Fawcett, 1970) and structural reinforce, which enhances the tensile strength of the 
flagellum that is required to overcome the shear forces in the female reproductive tract 
(Baltz et al., 1990). Anomalies in ODF were reported in spermatozoa of 
asthenoteratozoospermic men (Haidl et al., 1991; Chemes and Rawe, 2003, 2010). 
3.3.3 Neck piece (NP) 
The NP (also called connecting piece) (Fig. 5) has about 0.5 µm in length and 
its major components are the capitulum (a dense dome-shaped fibrous structure) and 
the SC (Fawcett, 1970; Grudzinskas and Yovich, 1995).  
The base of the nucleus is indented (implantation fossa) and covered by the 
BP, a layer of electron dense material that contacts with the SC (Pedersen, 1972). 
The columns are cross-striated with a periodicity of about 6.5 nm between segments, 
and each segment has nine or ten horizontal striations. The SC are formed 
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separately, become linked at a late stage in spermiogenesis and the ODF only attach 
to the distal ends of the SC in the mature spermatozoon. It is believed that the 
columns are articulated, and may give flexibility to the NP to allow bending without 
placing stress on the BP link (Grudzinskas and Yovich, 1995).  
The centrosome is a cytoplasmic structure that serves as the main microtubule 
organizing center of the cell as well as a regulator of cell-cycle progression. During 
formation of cilia, the centrosome replicates and individual centrioles migrate to the 
cell periphery where they anchorage to the cell membrane to become basal bodies 
from which Ax originates. In humans, the distal centriole disappears in 
spermiogenesis, after the sperm Ax being formed, leaving only few remnants in 
mature spermatozoa. Therefore, the mature spermatozoon has only one functional 
centriole, the PC, attached to the BP. The main role of the sperm PC is related with 
the process of fertilization and cell division of the fertilized oocyte. The PC is carried 
into the oocyte at fertilization, persists throughout sperm nuclear decondensation and 
organizes the sperm aster. This is a radial array of microtubules that promote 
pronuclear movement towards the center of the zygote. After that moment it replicates 
and originates the two asters of the zygote (Sathananthan et al., 1996; Nakamura et 
al., 2001; Chemes, 2012).  
3.3.4 Midpiece (MP) 
MP is about 3.5-5 µm in length and is characterized by the presence of a 
mitochondrial sheath in form of a helix that surrounds the axonemal complex and the 
nine ODF (Fig.5) (Holstein and Roosen-Runge, 1981). The mitochondrial helix is kept 
in form by multiple disulphide bridges composed by a selenium-rich protein that 
becomes a structural protein in mature spermatozoa (Piomboni et al., 2012). 
The human sperm mitochondria are positioned in four helices, and each helix 
is composed of 11-15 gyres with on average two mitochondria to each gyre. The 
human sperm mitochondria are more stable than those found in somatic cells, which 
may help to resist to the stretching and compression of the mitochondria during the 
flagellar beat (Grudzinskas and Yovich, 1995). Another difference is its ability to use 
lactate as an oxidative substrate and the presence of specific isoforms of proteins and 
isoenzymes, such as cytochrome c. These specific functional characteristics adapted 
sperm mitochondria for sperm motility (Gagnon and de Lamirande, 2006; Piomboni et 
al., 2012). The mitochondrial inner membrane is the site of energy production for the 
spermatozoa. However, is an ongoing debate if mitochondria oxidative 
phosphorylation is enough to generate the energy necessary for sperm flagellar 
motility. It has been suggested by some reports, that the energy source for sperm 
motility is mostly given by glycolysis (glycolytic enzymes are linked to the fibrous 
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sheath, which is near the beating Ax) instead by mitochondria oxidative 
phosphorylation (whose ATP production is far away from the beating Ax) (reviewed by 
Ford, 2006; Piomboni et al., 2012). Nevertheless, independently of its role in providing 
energy for sperm motility, mitochondria energy are involved in important cellular 
process such as cell defence against oxygen reactive species, apotosis and in 
intracellular and membrane events occurring during spermatogenesis, sperm 
maturation (in the epididymis), sperm capacitation (during interaction with the 
endometrium), and fertilization (reviewed by Rajender et al., 2010; Amaral et al., 
2013).  
In the MP it is also found a cytoplasmic droplet that consists of the remains of 
the residual cytoplasm. The cytoplasmic droplet is formed during the maturation 
phase of spermiogenesis, accomplished through the actions of Sertoli cells by a 
process known as “cytoplasmic extrusion”, which occurs before sperm are transported 
to the epididymis (Rengan et al., 2012). In the tubular lumen of the testis, Sertoli cells 
extrude and phagocyte most of the germ cell cytoplasm as “residual bodies”, the 
remnant of which becomes the cytoplasmic droplet. The human spermatozoa retain a 
small amount of the cytoplasmic droplet around the MP after spermiogenesis, with no 
negative effects to male fertility. The MP is the major site of water influx and cell 
volume regulation, thus the vesicles contained by cytoplasmic droplet are important 
when spermatozoa face hypoosmotic challenges, and therefore is an ideal location for 
the cytoplasmic droplet (Rengan et al., 2012).  
3.3.5 Principal Piece (PP) 
The major part of sperm flagellum is the PP with about 44-50 µm in length 
(Holstein and Roosen-Runge, 1981). The PP is separated from the MP by the An or 
Jensen’s ring (Fig. 3, 5) that is a traverse ring of dense material found at the end of 
the mitochondrial sheath. The plasma membrane of the flagellum adhere to the An in 
the mature spermatozoon, which, in humans, is semicircular in cross section with a 
curved caudal surface and a plane rostral surface (Fawcett, 1970). The role of An 
have been speculated for several years, however it was shown that the An is needed 
to maintain sperm membrane domains (Kwitny et al., 2010). 
The PP is distinguished from the other parts of flagellum by the presence of 
the FS, a cytoskeletal structure surrounding the Ax and the ODF. At the distal part of 
the PP the FS becomes more compact and smaller until completely disappear. At this 
time, the EP begins (Holstein and Roosen-Runge, 1981).  
The FS (Fig. 3, 5) is a unique characteristic of the spermatozoon and consists 
of two peripheral longitudinal columns, which are at the plane of the central 
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microtubules, connected together by a series of ribs. The ribs are composed of closely 
packed filaments and form a ring around the Ax (Holstein and Roosen-Runge, 1981; 
Grudzinskas and Yovich, 1995). The longitudinal columns are attached to ODF 3 and 
8 in the proximal part of the PP. When the ODF disappears, these columns become 
associated with microtubule doublets 3 and 8. The FS is formed at spermiogenesis 
acrosomal phase and its assembly proceeds from distal to proximal along the Ax 
(Oko, 1998; Eddy et al., 2003).  
The proteins that compose the FS have extensive disulphide bonding, which 
makes the whole structure extremely stable and resistant. These disulphide bonds are 
also important to stabilize the FS when sperm traverse the epididymis and undergo 
maturation (Eddy et al., 2003).  
Some important roles have been given to the FS (reviewed by Eddy et al., 
2003). It is believed that the FS influences and modulates the bending and the 
flagellar beat and is responsible for docking key components involved in signal 
transduction pathways, such as cAMP-signalling pathway, which are important to 
regulate processes that lead to fertilization. In addition, the FS anchors glycolytic 
enzymes that provide energy for motility of sperm (Eddy et al., 2003; Krisfalusi et al., 
2006). FS anomalies were associated to male infertility (Baccetti et al, 2005a, b; 
Escalier and Albert, 2006, Chemes and Rawe, 2010)  
3.3.6 End Piece (EP)  
In human spermatozoa, the EP has about 6 µm in length and begins when the 
FS completely disappears. Its only component is the Ax that, in the proximal part of 
the EP, generally maintains its structure, and is surrounded by the plasma membrane. 
However in the distal part, only single tubules in Ax are present (Holstein and Roosen-
Runge, 1981). Analysing the EP from the beginning to the end, the first structure that 
disappear are the arms of the doublets. At the same plane, the subunit A becomes 
hollow. Then, the two central microtubules terminate and two of the doublets move to 
the middle and are surrounded by seven spaced doublets. At the end, the EP 
becomes closer, is possible to observe a separation of the doublets and the beginning 
of the opening of the B subunits. This is followed by a successive termination of the 
remaining tubules as the end of the flagellum is reached (Pedersen, 1972).  
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4. MOLECULAR COMPONENTS OF THE SPERM FLAGELLUM 
 
In the previous section the general structure and morphology of human 
spermatozoa was focused. In this section we will give emphasis to the molecular 
components of the sperm flagellum, specifically to the main proteins and encoded 
genes present in the different structures of flagellum associated to sperm motility. The 
molecular composition of flagellum components has been studied mainly in sperm 
from marine invertebrates (such as sea urchins and tunicates) and in protists (such as 
Chlamydomonas and Tetrahymena) (Dutcher, 1995; Inaba, 2003, 2011).  The 
molecular components that will be addressed here are merely a small portion of all 
molecular components and interactions that may exist in the complex sperm 
flagellum. There is still a long journey to make in order to fully understand all 
molecular components and mechanisms that compound and are responsible for the 
assembly of the sperm flagellum.  
4.1. Axoneme 
The Ax (Fig. 6,7) is the flagellar motor of the sperm cells and the studies 
performed in marine invertebrates show that it is composed by approximately 250 
proteins (Dutcher, 1995). Despite the basic structure of the sperm Ax being quite 
conserved and similar, some structures, such as ODA and central pair projections, are 
different between Chlamydomonas and metazoan sperm (Inaba, 2007, 2011).  
 
Figure 7. A schematic drawing of the sperm axoneme. The legend of the sperm axoneme components is 
placed on the right. For more information about its structure see section 3.3.1 
   
The Ax is a sophisticated structure with a cytoskeleton, motors proteins, 
molecular chaperones, regulatory elements such as Ca2+, binding proteins and protein 
kinases/phosphatases (reviewed by, Inaba, 2003). 
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4.1.1 Tubulin 
The main structural component of microtubules is tubulin (alpha and beta 
tubulin), constituting about 70% of the protein mass in an Ax. They belong to a small 
family of globular proteins and are linked with a wide range of somatic cell functions, 
such as maintaining structure of the cell, movement of secretory vesicles, organelles, 
and intracellular substances and in cell division (Dutcher, 1995). The genes of α- and 
β-tubulin are highly conserved within and among species, with α- and β-tubulins 
sharing at least 60% of amino acid identity. The α- and β-tubulins are also similar 
between themselves as α -tubulins share 36–42% identity with β-tubulins. Besides α- 
and β-tubulins, the tubulin superfamily is composed by γ-, δ-, ζ- and ε- tubulins. 
Tubulins α-, β- and γ- are ubiquitous in eukaryotes and the genes that encodes this 
proteins are essential for microtubule polymerization. Tubulins δ- and ε- are 
widespread but not ubiquitous, whereas ζ-tubulin has been found only in kinetoplastid 
protozoa. However, knowledge about their role is still scarce (reviewed by(Oakley, 
2000; Dutcher, 2001).  
Tubulin molecules are arranged in rows to form protofilaments, which are then 
aligned side by side to form the microtubule walls. In doublets of the Ax, the A tubule 
is composed of 13 protofilaments and the incomplete B tubule is made up of 10 
protofilaments (Afzelius et al., 1995). Laterally and throughout most of the 
microtubule, α-tubulin molecules interact with other α-tubulin molecules, so does, β-
tubulin molecules. These laterally self-interaction of α-tubulin and β-tubulin molecules 
is necessary to the combination of the protofilaments that compose the microtubules 
(Oakley, 2000). Tubulin is often subjected to post-translational modifications, for 
example acetylation, palmitoylation, phosphorylation, polyglutamylation and 
polyglycation (reviewed by Rosenbaum, 2000; Hammond et al., 2008), that are 
important for proper binding and assembly of axonemal substructures to microtubules 
and for motility. For instance, it was demonstrated that the polyglutamylation of α-
tubulin plays a dynamic role in a dynein-based motility process (Gagnon et al., 1996).  
4.1.2 Dyneins 
Dyneins are motor proteins that convert the chemical energy contained in ATP 
into the mechanical energy of movement. Dyneins can be divided into two groups: 
cytoplasmic dyneins and axonemal dyneins (or flagellar dyneins). The axonemal 
dyneins are key elements to motility of eukaryotic cilia and flagella. 
The organisation of human ODA has not been examined but in other 
metazoan sperm, the ODA is comprised of two heavy chains (HC) of about 500 kDa; 
three to five intermediate chains (IC) of about 120–60 kDa; and six light chains (LC) 
with approximately 30–80 kDa each (Inaba, 2003). In its turn, the IDA is more 
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complex. In Chlamydomonas it was observed that the IDA has eight distinct inner arm 
HC, which are organized with various IC and LC into seven different molecular 
complexes, one two-headed isoform and six single-headed isoforms (Porter, 1996). 
The HC contains the motor machinery that is responsible for transducing 
chemical energy into directed mechanical force applied to the microtubule surface, 
possessing the sites of both ATP hydrolysis and ATP-sensitive microtubule binding 
(Asai and Koonce, 2001; Burgess and Knight, 2004). Each HC comprises three 
domains: (1) the N-terminal domain (also called stem domain), which may be involved 
in binding of the dynein to microtubules; (2) the C-terminal domain (also called a 
globular head), that includes a highly conserved central section with six AAA modules 
(AAA for: ATPases associated diverse cellular activities), considered to form a globular 
subdomain; and (3) the microtubule-binding domain (that forms the stalk domain).  
The N-terminal domain is connected to the C-terminal globular head. Regarding the 
AAA motifs, the first four possess P-loop motifs that are well conserved in all dynein 
sequences. The first P-loop-P1, is the site of ATP hydrolysis that leads to movement; 
the AAA modules 2 to 4 are non-hydrolytic and possess intact P-loops that possibly 
are capable of binding nucleotides. The two last AAA domains lack P-loops and are 
believed that consequently do not bind nucleotides. Between the 4 and 5 AAA 
modules is located the B-link, which is the functional contact between dynein and the 
microtubule (King, 2000; Asai and Koonce, 2001; Burgess et al., 2003; Burgess and 
Knight, 2004). The interzone between each AAA domain appears to be important for 
the conformational change during mechanochemical cycles, which presumably exerts 
the power stroke (Roberts et al., 2013). 
The IC and LC help to specify the intracellular location of the dynein, regulates 
its motor activity and are also a source of diversity between species (Asai and 
Koonce, 2001, Burgess and Knight, 2004). The IC participates in structural 
attachment of the DA to flagellar microtubules (King, 2000). Relatively to the LC, 
several functions have been recognised, such as redox-sensitive vicinal dithiols, Ca2+ 
binding (King, 2000) and intraflagellar transport (Pazour et al., 1998). It is known that 
phosphorylation/dephosphorylation of IC and LC leads to an alteration in motor 
activity (King, 2000). The variety of structure and function of these chains indicates 
that many regulatory mechanisms are present and needed for the proper sperm 
motility.  
Multiple dynein genes are found in the genomes of organisms with motile cilia 
and flagella. Phylogenetic analyses classify these into several groups, each of which 
may be associated with a specific function. Five human genes are known that encode 
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ODA dynein heavy chain (DHC) genes: DNAH5 (Gene ID: 1767, 5p15), DNAH8 
(Gene ID: 1769, 6p21), DNAH9 (Gene ID: 1770, 17p12), DNAH11 (Gene ID: 8701, 
7p21) and DNAH17 (Gene ID: 8632, 17q25.3) (Pazour et al., 2006; Yagi, 2009). 
Relatively to the IDA, there are eight human genes: DNAH1 (Gene ID: 25981, 
3p21.1), DNAH2 (Gene ID: 146754, 17p13.1), DNAH3 (Gene ID: 55567, 16p12.3), 
DNAH6 (Gene ID: 1768, 2p11.2), DNAH7 (Gene ID: 56171, 2q32.3), DNAH10 (Gene 
ID: 196385, 12q24.31), DNAH12 (Gene ID: 201625, 3p14.3), DNAH14 (Gene ID: 
127602, 1q42.12) (Pazour et al., 2006; Yagi, 2009). The IC and LC chains are thought 
to contain at least 5 genes, including DNAI1 (Gene ID: 27019, 9p13.3), DNAI2 (Gene 
ID: 64446, 17q25), DNAL1 (Gene ID: 83544, 14q24.3), DNAL4 (Gene ID: 10126, 
22q13.1), DNALI1 (Gene ID: 7802, 1p35.1) and TXNDC3 (Gene ID: 51314, 7p14.1) 
(National Center for Biotechnology Information (NCBI) database-accessed in 
December 2013). Phylogenetic analysis supports the assignment of DNAI1 and 
DNAI2 as outer dynein arm IC (Pazour et al., 2006).  
These chains regulate dynein activity, consequently mutations may result in 
abnormal ciliary ultrastructure and function. Mutations in some of these genes were 
already associated to syndromes such as primary ciliary dyskinesia (PCD, see Table I 
of the following section 5.1). 
4.1.3 Dynein Docking Complex and Dynein Regulatory Complex (DRC)  
The outer dynein arm docking complex (ODA-DC) is a structure that interacts 
directly with the DA being responsible for the assembly and binding of ODA at 
microtubules doublet in regular intervals (24nm). The ODA-DC contains three 
polypeptides (DC1-DC3) (Takada et al., 2002). The DC1 and DC2 polypeptides are 
quite similar. Both have three regions, totalling 236 and 178 amino acids, 
correspondently, that are >99% likely to form a coiled-coil structure. These two 
proteins potentially determine the spacing of the ODA (Takada et al., 2002). The DC3 
polypeptide has four motifs that possibly bind Ca2+, has important roles in the 
regulation of the ODA and also plays a role in calcium-regulated ODA activity (Casey 
et al., 2003). 
The DRC functions of dynein regulation and limitation of doublet sliding 
(Heuser et al., 2009), and is composed of six axonemal proteins (Piperno et al., 
1992). Studies using DRC mutants showed that some components of the DRC serve 
primarily to regulate activity, while others play a role in mediating structural 
interactions between the DA, the A-tubule of the outer doublet, and the RS (Gardner 
et al., 1994; Piperno et al., 1994). For instance, DRC components 3, 4, and 7 possibly 
stabilize the binding of IDA isoforms, whereas components 1 and 2 may form part of 
the binding site for both RS and certain inner arm subspecies (Gardner et al., 1994). 
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As far as we known, only three DRC components have been cloned and 
characterized at the molecular level: the DRC4 in Chlamydomonas (Rupp and Porter, 
2003); CMF70 in Trypanosoma brucei (Kabututu et al., 2010) and the DRC1 also in 
Chlamydomonas (Wirschell et al., 2013).  
4.1.4 Radial spokes (RS) and Central pair complex (CPC) 
The CPC is composed by two structurally asymmetric and biochemically 
distinct central microtubules, linked by central projections and surrounded by a fibrilar 
sheath. The central pair interacts with the RS, which by its turn are attached to each 
microtubules doublets (Fig. 7). The RS and CPC are essential for the regulation of 
DA. For instance, it was proposed that RS and CPC may be involved in converting 
simple symmetric bends into the asymmetric waveforms required for forward 
swimming and in the release of ATP inhibition in a controlled manner (Smith and 
Lefebvre, 1997;Smith and Yang, 2004). In addition, central pair may function like a 
distributor to provide a local signal to the RS that selectively activates subsets of DA 
(Omoto et al., 1999).  
The RS in Chlamydomonas flagella contains at least 23 distinct polypeptides, 
termed RS protein (RSP)1 to RSP23 with a combined molecular mass of 
approximately 1200 kDa (Yang et al., 2006). Some have been already cloned and 
important functions have been described. For example, RSP3 anchors the RS to the 
outer microtubule doublet, contains an AKAP (for A-kinase anchoring protein) domain 
and binds in vitro the cyclic AMP-dependent protein kinase (PKA) regulatory subunit 
(Gaillard et al., 2001). This could explain the fact that the regulation of DA by RS/CPC 
involves events of phosphorylation/dephosphorylation (Porter and Sale, 2000).  
In humans it has been already described at least seven radial spoke proteins 
and its encoding genes are: RSPH1 (Gene ID: 89765, 21q22.3), RSPH3 (Gene ID: 
83861, 6q25.3), RSPH4A (Gene ID: 345895, 6q22.1), RSPH6A (Gene ID: 81492, 
19q13.3) RSPH9 (Gene ID: 221421, 6p21.1) RSPH10B (Gene ID: 222967, 7p22.1) 
and RSPH10B2 (Gene ID: 728194, 7p22.1) (NCBI database 
http://www.ncbi.nlm.nih.gov/gene/ and Uniprot database, http://www.uniprot.org/, 
accessed July 2014). RSPH1 gene encodes a RS-head protein and is mainly 
expressed in respiratory and testis cells. It is important for the proper building of CPC 
and RS, since mutations in the RSPH1 leads to an abnormal axonemal configuration 
with CPC and RS defects (Kott et al., 2013; Onoufriadis et al., 2014). Castleman and 
collaborators found mutations in the RS genes RSPH4A and RSPH9 associated to 
anormalies in CPC (Castleman et al., 2009). 
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The CPC in Chlamydomonas flagella also contains approximately 23 
polypeptides (1-350 kDa) (Smith and Lefebvre, 1997) and possesses similar domains 
for molecular assembly and signalling, such as AKAP240 (Gaillard et al., 2001) and 
FAP221, whose mammalian orthologue is the CaM-binding protein primary ciliary 
dyskinesia protein 1 (PCDp1). The PCDp1 is known to coordinate the activity of 
specific dynein isoforms in the control of ciliary motility (DiPetrillo and Smith, 2010, 
2011).  
4.2. Outer dense fibres (ODF) 
The ODF in rat spermatozoa contains at least 14 polypeptides (Oko, 1988), 
whereas the human ODF consist of about 10 major proteins and of at least 15 minor 
proteins (Petersen et al., 1999).  
Some of its protein encode genes were already identified, and at least four 
(ODF1 to 4 genes) have been cloned and characterized in humans. For instance, the 
human gene that encodes one of the main ODF protein is the ODF1 (OMIM: 182878, 
8q22) and it is only expressed in testis. The protein codified by its gene (ODF1 
protein) contains leucine zipper motifs which appear to be responsible for self-
interaction and interaction with other ODF components (Shao et al., 1997). The N-
terminal leucine zipper motif of the ODF1 protein, allowed the isolation of the 
interacting proteins ODF2 (firstly called Odf84) (Shao et al., 1997), SPAG4 (Shao et 
al., 1999a) and SPAG5 (Shao et al., 2001).  The human ODF2 gene (Gene ID: 4957, 
9q34) is ubiquitously expressed in many cell types as various splicing variants (Shao 
et al., 1999b, Schweizer and Hoyer-Fender, 2009). ODF2 protein has been reported 
to play several important roles such as: formation of primary cilia (Soung et al., 2009) 
and sperm flagella (Tarnasky et al., 2010). It is also involved in the initial docking of 
centrioles to membrane (Hoyer-Fender, 2010). Moreover, is important to the basal 
foot formation and for polarized alignment of basal bodies and coordinated ciliary 
beating (Kunimoto et al., 2012) and for pre-implantation development (Salmon et al., 
2006). The ODF3 gene (Gene ID: 113746, 11p15.) encodes the ODF protein 3, 
localized in the flagella of elongated spermatids and along the entire length of the tail 
in mature sperm (Carvalho et al., 2002). The ODF4 gene (Gene ID: 146852, 17p13.1) 
encodes the ODF protein 4, expressed only in the testis (Kitamura et al., 2003).  
4.3. Centriole 
Centrioles are a small cylindrical structure that together with the pericentriolar-
material forms the centrosome, the major microtubule organising centre in animal 
cells. Among their important cellular roles, are the formation of Ax and flagella 
(Bettencourt-Dias and Glover, 2007).  
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PLK4 and SAS6 proteins are master regulators of centriole duplication. Its 
absence leads to a lack of centriole duplication, whereas an overexpression leads to 
an increase in the number of microtubule organising centre (Bettencourt-Dias et al., 
2005; Habedanck et al., 2005; Kitagawa et al., 2009). The proteins CEP135, SAS5 (or 
STIL), CP110, Centrin and Ana1/2/3 are also important for procentriole and centriole 
biogenesis and the CPAP protein plays an important role in centriole elongation 
(reviewed by Bettencourt-Dias and Glover, 2007; Brownlee and Rogers, 2013). 
Mutations in some of these regulators or in other components involved in centriole 
formation/function/duplication may lead to centriolar and centrosomal abnormalities, 
which by its turn, are involved in male infertility or in abnormal development of the 
embryos. Defects in centrosomes, have been reported to cause the anomalies in cilia 
in patients suffering from ‘‘ciliopathies’’, a group of disorders of ciliated cells, such as 
PCD. These disorders are also associated to male sperm immotility (reviewed by 
Chemes, 2012). 
4.4. Mitochondria 
Mitochondria contain about a thousand of distinct proteins involved in various 
metabolic pathways (Sickmann et al., 2003; Pagliarini et al., 2008). Despite the 
established role of mitochondria in energy production (Cooper, 2002), only 14% of its 
proteins act directly in energy metabolism. The majority are involved in maintaining 
and expressing the mitochondrial genome, in the transport of metabolites and in 
metabolism of amino acids, lipids, and iron (Sickmann et al., 2003). The crucial core 
machinery of mitochondrial gene expression consists of the mitochondrial 
transcription factor A and B2 (TFAM and TFB2, respectively) and the RNA 
polymerase. The TFAM has also a role in maintenance and packaging of 
mitochondrial DNA (mtDNA) (Kang et al., 2007; Kaufman et al., 2007). Mitochondrial 
biogenesis, respiratory function and control of the expression of genes encoding for 
cytochromes-c and cytochromes-c-oxidase subunits (vital for ATP production) are 
governed by nuclear factors, such as the nuclear respiratory factors 1 and 2 (NRF1 
and NRF2). NRF1/NRF2 are regulated by the PGC-1α, thus it is the master regulator 
of mitochondrial biogenesis (Hock and Kralli, 2009; Scarpulla, 2011; Wenz, 2013). 
Mitochondrial genetic diseases can result from defects in mtDNA in the form of 
deletions, point mutations or depletion, which, ultimately, causes loss of oxidative 
phosphorylation. They may be spontaneous, maternally inherited or a result of 
inherited nuclear defects in genes that maintain the mtDNA (Copeland, 2008). 
Mutations of the mtDNA in spermatogenesis cause male infertility because of its 
important role in energy production for mitosis, meiosis, sperm maturation, 
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capacitation and motility (Rajender et al., 2010). It was observed that high levels of 
mutant mtDNA are correlated to sperm immotility (Spiropoulos et al, 2002). An 
explanation could be that, the high levels of mutant mtDNA might increases the 
likelihood of reactive oxygen species that damage the mtDNA, and thus causing 
potentially deleterious effects on sperm function (Tremellen, 2008). 
4.5. Annulus (An) 
The An, in humans, is semicircular in cross section with a curved caudal 
surface and a plane rostral surface (Fawcett, 1970). The An is needed to maintain 
sperm membrane domains and its absence produces an interruption in the 
cytoskeleton at the MP-PP junction (Kwitny et al., 2010). 
Septins are essential structural components of the human and mouse An 
(Mostowy and Cossart, 2012), forming a ring that forms a diffusion barrier required for 
the mechanical and structural integrity of the sperm (Ihara et al., 2005; Kwitny et al., 
2010).  
Until now there have been identified 14 human septins, with SEPT1, SEPT4, 
SETP6, SEPT7 and SEPT12 being located at the An (Ihara et al., 2005; Steels et al., 
2007; Lin et al., 2011). Using mouse knockouts it was showed that SEPT4 is essential 
for the structural and mechanical integrity of the spermatozoon, including for proper 
mitochondrial architecture and establishment of the An (Ihara et al., 2005; Kissel et 
al., 2005). Protein SEPT7 is involved in the regulation of sperm maturation and sperm 
morphology (Chao et al., 2010). Consequently SEPT4/7 were suggested to be used 
as biomarkers for monitoring the status of spermiogenesis (Sugino et al., 2008). In 
humans, SEPT12 is expressed only in spermatozoa, namely in the head, neck and An 
(Steels et al., 2007; Lin et al., 2011, 2012). Important roles in spermiogenesis, 
including sperm nuclear integrity and tail development were attributed to SEPT12 (Lin 
et al., 2009, 2012; Miyamoto et al., 2012; Kuo et al., 2013). 
Tat1 is an anion transporter of the SLC26 family and is another critical 
component of the sperm An. It is specifically expressed in male germ cells and co-
expressed with Sept4. This anion transporter is thought to be essential for proper 
sperm tail differentiation and motility (Touré et al., 2007; Lhuillier et al., 2009).  
4.6. Fibrous Sheath (FS) 
The FS is a cytoskeletal structure exclusive of the PP of sperm and surrounds 
the Ax and ODF. The FS is believed to influence the degree of flexibility, plane of 
flagellar motion and the shape of the flagellar beat. 
Although the majority of studies on FS proteins were performed in rodents, 
several proteins were already identified in the human FS too (Beecher et al., 1993; 
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Kim et al., 1995, 1997; Turner et al., 1998; Vijayaraghavan et al., 1999; Naaby-
Hansen et al., 2002).  
Three of the main FS proteins are of the AKAP family (Eddy et al., 2003). 
AKAP are scaffolding molecules that organize molecular complexes whose function is 
determine the precise location and timing of signal transduction events, and combine 
signal transduction and signal termination molecules in order to modulate signalling 
pathways. AKAP proteins sequester enzymes such as protein kinases and 
phosphatases with appropriate substrates to the coordination of phosphorylation and 
dephosphorylation events (Langeberg and Scott, 2005). The AKAP4 gene is 
expressed in the post-meiotic phase of spermatogenesis and encodes an AKAP4 
protein, which is the most abundant protein and a major structural component of FS. It 
is restricted to the PP of the flagellum, has two regions of homology with PKA-
anchoring domains (a characteristic of AKAP proteins) and plays a major role in 
completing FS assembly. It is also important for sperm motility (Turner et al., 1998; 
Brown et al., 2003; Eddy et al., 2003). The human AKAP3 gene encodes the second 
major protein of the FS (Vijayaraghavan et al., 1999), the AKAP3 protein. It has a 
single PKA binding site and was detected only in the circumferential ribs. It was 
proposed that AKAP3 gene is involved in organizing the basic structure of the FS 
(Mandal et al., 1999; Brown et al., 2003; Eddy et al., 2003).  
The FS is composed by many more proteins, such Ropporin; Rhophilin and 
“Calcium-binding tyrosine phosphorylation regulated protein” (Eddy et al., 2003), 
which are extremely important for FS assembly and function, and thus for sperm 
motility. Other FS proteins, as a mu-class glutathione-s-transferase, have raised the 
possibility that the FS could also have a role in protect sperm from oxidative stress 
(Fulcher et al., 1995).  
Another important class of FS proteins are the glycolytic enzymes. Some 
studies have suggested that the mitochondrial energy production may not be enough 
to sustain the sperm motility and propose glycolyis as a main method of energy 
production for flagellar motility (Ford, 2006; Piomboni et al., 2012). Most of the 
glycolytic enzymes are localised in PP and glycolysis seems to be restricted to the 
PP. Some of the glycolytic enzymes, including two spermatogenic cell-specific forms 
(glyceraldehyde 3-phosphate dehydrogenase (GAPD) and hexokinase 1), are tightly 
associated with the FS (Eddy et al., 2003; Turner, 2003; Ford, 2006). Another study 
showed that male mice lacked progressive motility when the gene for sperm specific 
GAPD has been ‘knocked out’, demonstrating the importance of the glycolysis and the 
glycolytic enzymes of FS to sperm motility (Miki et al., 2004). 
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5. FLAGELLAR ABNORMALITIES AND GENETIC BASES OF 
SPERM IMMOTILITY IN HUMANS  
 
Sperm motility is crucial to natural fertilization occur. Sperm only becomes fully 
motile after being exposed to several of external and intracellular factors during its 
journey through epididymis and female reproductive tract (Luconi et al., 2006; Aitken 
et al., 2007). Flagellum motility is a consequence from ondulatory waves propagating 
backwards that create forward propulsive thrust along the axis of the flagellum. It is 
created by the motor activities of the axonemal DA working against the stable 
microtubule doublets. Signals are transmitted from the CPC through the RS to the 
DRC whose regulate the dynein activity. The flagellar beat starts with the 
phosphorylation of the dynein, which activates the ATPase and starts the conversion 
of chemical energy from ATP hydrolysis into mechanical energy for motility. In the 
presence of ATP, dyneins produce a unidirectional force towards the minus end of 
microtubules to generate sliding forces. Consequently, one DA (first dynein) binds to 
the B tubule of the adjacent outer doublet and generates a downward stroke, resulting 
in the adjacent microtubules sliding past between pairs of outer doublets. This 
sequence will be repeated along the length of the microtubules resulting in the 
propagation of the flagellar bend for all flagellum (Turner, 2003; Gagnon and de 
Lamirande, 2006; Luconi et al., 2006). Therefore, DA activity must be precisely 
coordinated both along the length and around the circumference of the flagellum 
(Heuser et al., 2009). 
The sperm motility is thus, a highly complex process with several structural 
and molecular elements and metabolic pathways involved. Due to this highly 
complexity, any alteration in external and/or internal factors regulating sperm motion 
as well as in cellular structure and metabolism involved in generating flagellar beat 
may result in defects in sperm motility, which consequently results in male infertility.  
Asthenozoospermia is the medical term for reduced sperm motility and is one 
of the main male pathologies underlying infertility (Curi et al., 2003; Ortega et al., 
2011). The aetiology of asthenozoospermia is not simple to unravel and often remains 
unexplained. Ultrastructural defects in the sperm flagellum caused by genetically 
inherited and congenital defects (Chemes et al., 1998; Chemes, 2000) and 
necrozoospermia (low percentage of live, and high percentage of immotile, 
spermatozoa in the ejaculate) are the main causes of asthenozoospermia (Curi et al., 
2003; Ortega et al., 2011).  
Mitochondria provide energy for spermatogenesis, sperm maturation and 
capacitation, and are as well involved in cell differentiation, ROS generation, 
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apoptosis and calcium signalling (Amaral et al., 2013).  Therefore, dysfunctions of the 
human mitochondrial sheath and mutations mtDNA are also a significant cause of 
asthenozoospermia (Spiropoulos et al., 2002; Rajender et al., 2010; Piomboni et al., 
2012). In addition, the lack of the An and disorganization of the MP-PP junction are 
associated with human asthenozoospermia (Ihara et al., 2005; Lhuillier et al., 2009). 
 In mouse, many mutations in genes coding for varied products as flagellar 
transport proteins, structural, motor and signalling proteins are known to cause 
anomalies in the sperm flagellum leading to motility disorders (Escalier, 2006; 
Yatsenko et al., 2010; Inaba, 2011). Unfortunately, in humans a strict association 
between mutations in some genes and alteration in sperm motility are still very scarce. 
However, due to the high degree of conservation of many of these genes among mice 
and humans, some genes, isolated or associated to syndromes, already have been 
proved to be responsible for some cases of human infertility associated with poor 
sperm motility (Inaba, 2011). Two main disorders are associated with poor sperm 
motility: Primary Ciliary Dyskinesia (PCD) and Dysplasia of the Fibrous Sheath (DFS).  
5.1. Primary Ciliary Dyskinesia (PCD) 
PCD (also called immotile cilia syndrome), was first described more than a 
century ago by Afzelius (Afzelius et al., 1975; Afzelius, 1976). PCD (OMIM: 244400) is 
a genetically heterogeneous, autosomal recessive disease that is characterized by a 
generalized paralysis of ciliated cells, including sperm and respiratory cilia, resulting in 
recurrent infections of the respiratory tract. 
Kartagener syndrome (KS), is characterized by the combination of situs 
inversus (reversal of the internal organs), chronic sinusitis, and bronchiectasis, and 
occurs in about 50% of PCD. Most men with PCD have nearly 100% immotile 
spermatozoa and thus are infertile. The estimated incidence of PCD is approximately 
1 per 15,000 births, but the prevalence of PCD is difficult to determine, mainly due to 
difficulties related to the diagnosis, ranging from 1/2,000 to 1/40,000 (reviewed in 
Boon et al., 2013; Lie and Ferkol, 2007). In the majority of cases, the results of 
electron microscopic analysis of sperm cells reveal that microtubule doublets of the Ax 
lack DA. In addition, it was also found in PCD patient’s absence or dislocation of the 
central microtubules, defects of RS and doublets abnormalities (Afzelius and 
Srurgess, 1985; Afzelius et al., 1995; Chemes and Rawe, 2003). 
Given that the typical diagnostic of PCD is the absence of DA, the 
investigations into the genetic basis of PCD have been focused on DA proteins and 
several genes are known to be associated with PCD (Table I). The first gene in which 
mutations were found to be associated with PCD was DNAI1, which is an axonemal 
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dynein IC gene, found in the ODA, and localized on 9p13-p21 (Pennarun et al., 1999). 
Mutations of DNAI1 have been identified in a patient with PCD/KS, whose ODA are 
often, but not always, absent or shortened (Pennarun et al., 1999; Guichard et al., 
2001; Zariwala et al., 2006). This gene has been one of the most studied, although a 
lower occurrence was described (about 10% of PCD patients) (Failly et al., 2008; 
Djakow et al., 2012). The gene DNAH5, localized at 5p15.2, comprises 79 exons and 
encodes a HC of the ODA. Defects of the ODA were found associated with DNAH5 
mutations in patients with PCD (Olbrich et al., 2002; Hornef et al., 2006). Patients 
without DNAH5 mutations did not show ODA defects neither isolated IDA defects 
(Hornef et al., 2006). These data suggest that DNAI1 and DNAH5 genes are 
important to the function of the ODA complex. Mutations in the DNAH5 gene are 
comparatively more frequent in PCD cases than mutations in DNAI1, although 
mutations in both genes are present in up to 38% of all patients with PCD (Geremek 
and Witt, 2004; Failly et al., 2008, 2009; Djakow et al., 2012; Boon et al., 2013). 
The human CCDC39 gene is localized at 3q26.33 and encodes a protein that 
was shown to be essential for the assembly of IDA and of the DRC. Thus, mutations 
in CCDC39 results in failure to correctly assemble of IDA complexes, the DRC, the 
CPC and the RS, thus causing axonemal disorganization and dyskinetic beating 
(Merveille et al., 2011). The CCDC40 gene, located at 17q25.3, encodes a CCDC40 
protein. Mutations in CCDC40 gene were found in subjects with PCD whose 
microscopic analyses showed defects in several axonemal structures, including 
disorganization of the microtubule doublets, absent or shifted central pair, reduction in 
the mean number or absence of IDA, and abnormal RS and nexin links. Nevertheless 
the ODA appeared normal (Becker-Heck et al., 2011). Moreover, CCDC40 appears to 
be required for axonemal recruitment of CCDC39 gene. It also physically interacts 
with the other axonemal components and may serve as a part of the Ax structural 
scaffold, possibly as a new DRC component (Becker-Heck et al., 2011). CCDC39 and 
CCDC40 proteins are considered integral components of the DRC and play a role in 
IDA attachment (Becker-Heck et al., 2011; Merveille et al., 2011). A recent study, 
using next generation sequencing (NGS) had identified mutations in both genes 
among 69% of individuals with PCD with IDA and CPC defects that are 
indistinguishable by microscopy (Antony et al., 2013). 
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Table I. List of genes known to be associated to PCD and main axonemal ultrastructural defects showed in PCD 
patients 
Gene 
Gene 
Location 
Molecular Function 
Main ultrastructural 
defect 
Key reference 
ARMC4 
10p12.1-
p11.23 
Axonemal docking and targeting 
of ODA components 
Marked reduction of ODA (Hjeij et al., 2013) 
DNAAF3 19q13.4 
Assembly of axonemal IDA and 
ODA and dynein complexes 
Absence of ODA and IDA 
(Mitchison et al., 
2012) 
C21orf59 21q22.1 DA assembly 
Absence of both ODA and 
IDA components 
(Austin-Tse et al., 
2013) 
CCDC103 17q21.31 
Fundamental factor for DA 
binding to cilia microtubules 
Partial loss of ODA 
complexes 
(Panizzi et al., 
2012) 
CCDC114 19q13.33 
Component of the ODA docking 
complex 
Absence of ODAs 
(Onoufriadis et 
al., 2013) 
DRC1 2p23.3 Regulation of the dynein motors 
Severe defects in assembly 
of the N-DRC structure 
(Wirschell et al., 
2013) 
CCDC39 3q26.33 
Assembly of DRC and IDA 
complexes 
Incorrect assembly od IDA, 
DRC, CPC and RS   (Merveille et al., 
2011)  
(Antony et al., 
2013) 
CCDC40 17q25.3 
Misplacement of the 
doublets and CPC; 
abnormal RS and defective 
assembly of IDA and DRC 
DNAAF1 
(LRRC50) 
16q24.1 
Pre-assembly and/or targeting of 
DA complexes 
Marked reduction of both 
ODA and IDA 
(Loges et al., 
2009) 
DNAAF2 
(KTU) 
14q21.3 Pre-assembly of DA complexes 
Absence or defects of 
ODA and IDA 
(Omran et al., 
2008) 
DNAH11 7p21 Encodes a ciliary ODA protein 
Normal axonemal 
ultrastructure 
(Knowles et al., 
2012) 
DNAH5 5p15.2 
Important for function of the ODA 
complex 
Absence of ODA 
(Olbrich et al., 
2002) 
DNAI1 9p13.3 
(Pennarun et al., 
1999) 
DNAI2 17q25 Assembly of ODA complexes ODA defects 
(Loges et al., 
2008) 
DNAL1 14q24.3 
Involved in the interaction of the 
axonemal DLC1 with DHC and 
tubulin 
Absence or markedly 
shortened ODA. 
(Mazor et al., 
2011) 
DYX1C1 15q21.3 
Important for axonemal dynein 
assembly 
Disruptions of ODA and 
IDA 
(Tarkar et al., 
2013) 
HEATR2 7p22.3 Assembly or transport of DA Absence of DA 
(Horani et al., 
2012) 
HYDIN 16q22.2 N.D. Defects in CPC 
(Olbrich et al., 
2012) 
LRRC6 8q24.22 
Assembly/ transport and 
transcriptional regulation of DA 
and dynein proteins 
Absence or defects of 
ODA and IDA 
(Horani et al., 
2013) 
RSPH1 21q22.3 A radial-spoke-head protein CPC and RS defects (Kott et al., 2013) 
RSPH9 6p21.1 
Components of the RS head Abnormalities in CPC 
(Castleman et al., 
2009) RSPH4A 6q22.1. 
SPAG1 8q22.2 
Assembly and/or trafficking of the 
axonemal DA 
Defects in ODA and IDA 
(Knowles et al., 
2013) 
NME8 
(TXNDC3) 
7p14.1 
Critical role in the ODA due to its 
ability to bind to the MTS. 
Partial lack and reduction of 
ODA 
(Duriez et al., 
2007) 
ZMYND10 3p21.3 
Required for IDA and ODA 
assembly 
Absence of ODA and IDA 
(Moore et al., 
2013) 
 
CPC- Central Pair Complex; DA- Dynein Arms; DLC- Dynein Light Chain; DHC- Dynein Heavy Chain; ODA- Outer 
Dynein Arms; IDA- Inner Dynein Arms; DRC- Dynein Regulatory Complex; N-DRC- Nexin-Dynein Regulatory 
Complex; N.D. Non-defined; RS-radial spokes 
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5.2. Dysplasia of the Fibrous Sheath (DFS) 
Dysplasia of the Fibrous Sheath (DFS), also called stump tail syndrome, is one 
of the most severe abnormalities of the sperm flagellum and causes extreme 
asthenozoospermia (Chemes et al., 1998; Chemes and Rawe, 2003, 2010). Marked 
hyperplasia and disorganization of the FS is the typical diagnostic finding in these 
cases. In addition, under light microscopy, the majority of sperm from affected 
individuals have short, thick, irregular flagella with no clear distinctions among the MP, 
PP and EP. From electron microscopy analysis it is also observed partial or total lack 
of DA, absence of the CPC (in about half of the cases), absence of a normal An and 
disassemble of the mitochondrial sheath. As a consequence, the hypertrophic FS 
extends up to the sperm neck (Chemes et al., 1998; Chemes, 2000; Baccetti et al., 
2005a, 2005b; Chemes and Rawe, 2010, 2003; Moretti et al., 2011). Although only 
occasionally associated with lack of IDA/ODA, DFS is considered a variant of PCD. 
In humans, the AKAP3 and AKAP4 proteins are the most abundant structural 
proteins of the FS (see previous section 4.6).  
To date, there is no therapeutic procedures to DFS phenotype, which aligned 
to the familial incidence and association with dynein deficiency in respiratory cilia, 
suggests that the DFS may have an autossomic recessive inheritance (Chemes and 
Rawe, 2010, 2003), but it is not clearly yet. Until now only mutations in AKAP3 and 
AKAP4 genes have been associated to the DFS phenotype (Chemes et al., 1998; 
Baccetti et al., 2005a, 2005b; Moretti et al., 2007). Miki and collaborators, 
demonstrated that male mice lacking AKAP4 protein were infertile, had reduced 
sperm motility, the FS was incompletely developed, and that other proteins usually 
found in the principal piece region of the flagellum were either absent or reduced in 
amount (Miki et al., 2002). Baccetti et al, detected deletions in AKAP3/4 binding 
regions and a moderate diffuse signal after immunostaining for human AKAP4 protein 
in DFS patients (Baccetti et al., 2005a, 2005b). However, there is still controversy 
since strong evidences for the involvement of specific genes in the pathogenesis of 
DFS are not yet available (Turner et al., 2001; Chemes and Rawe, 2010).  
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6. OBJECTIVES 
 
A group of five asthenozoospermic patients from two Assisted Reproductive 
Medicine centres (Hospital Centre of Vila Nova de Gaia (CHVNG) (n = 4) and Centre 
of Reproductive Genetics Prof. Alberto Barros (CGR) (n=1)) were previously study by 
transmission electron microscopy and their sperm ultrastructural analysis was 
reported in detailed by Sousa and co-workers (Sousa et al., 2014) and is also 
described in attachment 1.  
This ultrastructural analysis revealed 4 cases with DFS associated with 
disrupted CPC, RS, DA and doublets; and one patient with situs inversus (compatible 
with KS), who presented absence of DA and nexin bridges. Therefore, the objective of 
the present work was to identify genetic alterations that could explain patients’ 
phenotypes.   
The genes AKAP3, AKAP4, CCDC39, CCDC40, DNAI1, DNAH5 and RSPH1 
are genes involved in the assembly/composition of the FS (AKAP3, 4) and Ax 
(CCDC39, CCDC40, DNAI1, DNAH5 and RSPH1), namely DA, RS and CPC. 
Mutations in these genes were associated to defects in structures that are abnormal in 
the patients selected and also associated to sperm immotility. 
To start this study, we proposed to test if mutations in these genes could be 
related with the observed defects in flagellar structures of infertile men with total 
absence of sperm motility. In that way, we will amplify by polymerase chain reaction 
(PCR) and sequence by the Sanger sequencing method the exonic regions of the 
selected genes and analyse the data with the help of bioinformatics resources.  
With this work we expect to be able to offer a genetic diagnosis to the patients, 
find potential genetic markers for individuals with this medical condition and open the 
way for further investigations and the development of future genetic treatments.  
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Methods 
 
1. PATIENT, ETHICAL CONSIDERATIONS AND 
BIOLOGICAL MATERIAL 
 
We performed a genetic diagnostic of five individuals with total absence of 
sperm motility from two Portuguese Assisted Reproductive Medicine centres: the 
Hospital Centre of Vila Nova de Gaia (CHVNG) and the Centre of Reproductive 
Genetics Prof. Alberto Barros (CGR). In compliance with the National Law on 
Medically Assisted Procreation (Law 32/2006) and the guidelines of the National 
Council on Medically Assisted Procreation (CNPMA, 2008), semen and blood 
samples were used with the written informed consent of the patients. 
Patients’ sperm ultrastructural analysis was previously reported in detailed 
(Sousa et al., 2014). In Attachment 1 is escribed the methodology applied by Sousa et 
al. (2014) to perform the transmission electronic analyses of these patients and its 
main results. Briefly, Patient 1 and 4 with DFS associated with absence of the 
annulus, CPC and RS (Patient 1: also with allergies and chronic sinusitis). Patient 3, 
with chronic bronchitis, also presented DFS associated with absence of the annulus, 
CPC, RS, DA and nexin bridges. Patient 2 had a different presentation of DFS, which 
was associated with an intact annulus and disorganization of doublets. Finally, patient 
5 presented situs inversus, severe respiratory symptoms (nasal polyps, chronic 
sinusitis, rhinitis and bronchitis) and the sperm flagellum lacked DA and nexin bridges. 
The clinical features of patient 5 are compatible with the KS, however the saccharin 
test and the measurement of nasal nitric oxide, which are the most popular screening 
tests for PCD, were not performed. Thus, despite the clinical features being quite 
compatible, we cannot affirm that this patient present a KS. 
2. STUDIED GENES  
We evaluated seven different genes that encode essential proteins of the 
sperm flagellum, AKAP3 (NM_001278309.1), AKAP4 (NM_003886.2) CCDC39 
(NM_181426.1), CCDC40 (NM 017950.3), DNAH5 (NM_001369.2), DNAI1 
(NM_001281428.1) and RSPH1 (NM_080860.3) (Table II). Although the majority of 
the patients had a defined diagnosis, as all presented anomalies in common flagellar 
structures, we analysed all genes in all patients.  
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Table  II. List of selected genes and a summary of the main phenotype changes. 
 
Gene Accession number 
Gene 
Location 
Molecular Function 
Main ultrastructural 
defect1 
Key reference 
AKAP3 NM_001278309.1 12p13.3 
Major structural 
proteins of FS 
Marked hyperplasia and 
disorganization of the FS 
 Baccetti et 
al., 2005a, 
2005b; 
Chemes and 
Rawe, 2010 
AKAP4 NM_003886.2 Xp11.22 
CCDC39 NM_181426.1 3q26.33 
Assembly of DRC 
and IDA complexes 
Incorrect assembly od 
IDA, DRC, CPC and RS   
Merveille et 
al., 2013; 
Antony et al., 
2013 CCDC40 NM 017950.3 17q25.3 
Misplacement of the 
doublets and CPC; 
abnormal RS and 
defective assembly of 
IDA and DRC 
DNAI1 NM_001281428.1 9p13.3 
Important for 
function of the ODA 
complex 
Absence of ODA 
Pennarun et 
al., 1999  
DNAH5 NM_001369.2 5p15.2 
Olbrich et al., 
2002 
RSPH1 NM_080860.3 21q22.3 
A radial-spoke-head 
protein 
CPC and RS defects 
(Kott et al., 
2013) 
1 Associated to mutations in referred genes and detectable by TEM.  
Abbreviations used: CPC-Central Pair Complex; DRC- Dynein regulatory complex; IDA: Inner Dynein Arms; 
ODA: Outer Dynein; FS: Fibrous Sheath; RS-Radial Spoke.  
 
3. BLOOD COLLECTION 
Blood samples were collected, using EDTA as anticoagulant, at the Centre of 
Medical Genetics Jacinto Magalhães, Hospital Centre of Porto (CGM-CHP).  
4. EXTRACTION OF DNA  
DNA from patients peripheral blood lymphocytes were extracted following the 
salting out method (Miller et al., 1988), quantified by a NanoDrop spectrophotometer 
ND-1000 (Version 3.3; LifeTechnologies; California, United States of America (USA)) 
and stored at 4ºC. Aliquots with 100ng/µl of DNA were made and stored, also at 4 ° C.  
5. PRIMER DESIGN 
The sequences of the interest genes were retrieved using the NCBI 
(http://www.ncbi.nlm.nih.gov/) and the UCSC (University of California, Santa Cruz) 
Genome Browsers (http://genome.ucsc.edu/index.html). These sequences were 
inserted in the GenMol program (CGM-CHP institutional use, unpublished), which 
gives a user friendly interface to visualize the sequences and allows an easier 
identification of the exonic regions. Then, the Primer Express software 
(LifeTechnologies) was used to design primers that covered all exonic regions 
previously identified (with exception of the gene DNAH5 in which were only designed 
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primers for forty of a total seventy-nine, known to harbour the major number of 
mutations (Djakow et al., 2012)). 
 Primer design parameters were: primer length 18-25 bp; percentage of GC 40%-
60%; amplicon length (AL) 400-650 base pairs (bp); and temperature melting (Tm) 
59Cº-62Cº. Some primers had punctual modifications in the parameters. The total list 
of primers used, with reference to the modifications in design parameters are listed in 
Attachment 2. Each designed primer pair was tested against: i) the presence of 
dimers using the FastPCR software (version 3.7.7; Institute of Biotechnology, 
University of Helsinki, Finland); and ii) their specificity towards the regions of interest 
identified using PrimerBlast tool (Ye et al., 2012). Finally, primers were aligned with 
the total sequence of the gene to verify their annealing positions, using the software 
PrimerShow, at http://www.bioinformatics.org/sms/primer_show.html (Perry III, 2002). 
6. POLYMERASE CHAIN REACTION 
The gene regions of interest identified were amplified, using the primers 
previously designed, by polymerase chain reaction (PCR), in a thermocycler of 
models 9700, 9800 or VERITI (LifeTechnologies). 
PCR conditions were optimized to each primer pair (see Attachment 2). For 
that purpose DNA from a healthy man was used as a control. Four PCR programs 
were applied: (1) Stand-38c, with an initial denaturation at 95°C for 2 min, followed by 
thirty-eight cycles of 95°C for 45 s, specific annealing temperature (Ta, listed in tables 
of attachment 2) for 30 s, and 72°C for 1 min, with a final extension at 72°C for 10 
min; (2) Stand-35c, with an initial denaturation at 95°C for 10 min, followed by thirty-
five cycles of 95°C for 1 min, specific Ta (listed in tables of attachment 2) for 30 s, and 
72°C for 2 min, with a final extension at 72°C for 10 min; (3) Multi-Dmsc, a PCR with 
an initial denaturation at 95°C for 10 min, followed by thirty cycles of 95°C for 1 min, 
with a slower ramp reduction to 58/63°C for 30 s, and 72°C for 1 min, with a final 
extension at 72°C for 10 min; and (4) High-GC, a PCR with an initial denaturation at 
95°C for 5 min, followed by forty cycles of 95°C for 45 s, 58°C for 30 s, and 72°C for 1 
min, with a final extension at 72°C for 10 min. 
The PCR reaction mixture for the three first conditions (30 μl) contained: 15µl 
of PCR Master Mix (Promega, Madison, USA); 12 µl of sterile bidistilled water, 1 µl of 
each primer at 10 pmol/µl (Thermo Fisher Scientific, Einsteinstrasse, Germany) and 1 
µl of DNA at 100ng/µl. For the High-GC PCR condition, the reaction mixture (30 µl) 
contained: 12,5 µl of PCR Master Mix (Promega);  1,5 µl of sterile bidistilled water; 5 
µl of Betaine 5M (Sigma-Aldrish, St. Louis, USA); 1,5 µl of DMSO (Bioline, London, 
United Kingdom (UK)), 1 µl of each primer at 10 pmol/µl (Thermo Fisher Scientific) 
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and 2,5 µl of DNA at 100ng/µl. To amplify more complex genomic regions, the PCR 
Master Mix was replace by either: i) EmeraldAmp Max HS PCR Master Mix (Takara 
Bio, Shiga, Japan), which includes a high yield, Hot Start (HS) PCR enzyme, gel 
loading dye (green) and a density reagent in a 2X Taq PCR Master Mix format; ii) 
ImmoMix™ Red (Bioline), which includes a heat-activated thermostable DNA 
polymerase and gel loading dye (red); and iii)  DreamTaq Green PCR Master Mix 2X 
(Thermo Fisher Scientific).The list of all the PCR conditions and reaction mixture used 
for amplify each region are also detailed described in Attachment 2.  
PCR products were analyzed by 2% agarose gel electrophoresis: mix of TAE 
1X SeaKem LE Agarose (Lonza, Rockland, USA), and 5µL/100ml of GelRed Nucleic 
Acid Gel Stain, 10,000X in water (Biotium, California, USA) and were used phiX174 
DNA BsuRI/HaeIII Marker, ready-to-use (New England BioLabs, County Road 
Ipswich, USA) as a marker for sizing and approximate quantification of small double-
stranded DNA fragments. Finally, the PCR products were visualized and 
photographed by LAS-3000 (version 2.2, Fuji Film, Tokyo, Japan).  
7. SANGER DNA SEQUENCING 
Following successful PCR amplification, reactions were enzymatically purified 
using Illustra ExoStar kit (GE Healthcare- Buckinghamshire, UK). A new asymmetric 
PCR was prepared based on Sanger sequencing method, where random 
incorporation of chain-terminating dideoxynucleotides is promoted by a modified DNA 
polymerase, generating several DNA chains with different sizes. For this asymmetric 
PCR, BigDye Terminator v1.1 Cycle Sequencing Kit (LifeTechnologies) was used. 
Next these reactions were purified using a size selection column method Performa 
DTR (for Dye Terminator Removal) (EdgeBio, Maryland, USA). In the final step, the 
obtained products were resolved and analysed by high resolution electrophoresis in a 
3130xl genetic analyzer (LifeTechnologies) 
8. EXOME SEQUENCING BY NEXT-GENERATION 
SEQUENCING  
The exome of the patient 5, compatible with KS, was sequenced using the 
AmpliSeq strategy in the Ion Proton NGS platform. A total of 75 ng of high quality 
DNA from the patient were amplified in twelve primer pools amplicons (200pb of 
average size) with the Ion AmpliSeq™ Exome Library Preparation kit (Life 
Technologies). The sample was barcoded with the IonExpress Barcode Adapter (Life 
Technologies) to enable pooling of two exomes per chip. To evaluate the quality of the 
library a High Sensitivity DNA Kit in Bioanalyzer (Agilent, California, USA) was used. 
The library was quantified using Ion Library Quantitation Kit (Life Technologies). 
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Subsequently, library fragments were clonally amplified by emulsion PCR using the 
Ion PI Template OT2 200 kit v2 and the Ion OneTouch 2 System (Life Technologies), 
and the positive Ion Sphere Particles enriched in the Ion OneTouch exome 
sequencing machine (Life Technologies). Finally, these enriched positive spheres 
were loaded in Ion PI chip v2 and sequenced in the Ion Proton System (Life 
Technologies) at Genoinseq (Biocant, Cantanhede, Portugal).  
After the Ion Proton adapter sequences and low quality bases trimming using 
Torrent Suite software (Life Technologies), reads were mapped against the human 
reference genome hg19 using Torrent Mapping Alignment Program (version 4.0.6, 
Life Technologies). Variant calling was performed by running Torrent Variant Caller 
plugin (version 4.0), using the optimized parameters for exome sequencing 
recommended for Ampliseq sequencing (Life Technologies). The obtained Variant 
Call Format (VCF) file was analysed in GEMINI software (Paila et al., 2013) for 
annotation and prioritization. Variant filtering was performed using a list of 67 
candidate genes previously selected based on the literature (Pereira, in press; 
Attachment 3) and variants matching the autosomal recessive disease model (either 
homozygous or two heterozygous variants in the same gene). The Ion Reporter™ 
Software (Life technologies) was also used to filter rare variants by Gene Ontology 
(Ashburner et al., 2000), using the key words: sperm, flagellar, motility, axoneme and 
dynein. Candidate variants were manually checked on the Binary Alignment Map 
(BAM) file through GenomeBrowse version 2.0.2 (Golden Helix, Bozeman, United 
States). Seven manually checked variants were selected and submitted to PCR 
amplification and Sanger sequencing for confirmation as previously described. The 
detailed list of primers and PCR conditions used to perform these confirmations is 
available at Attachment 4. 
9. DATA ANALYSIS AND INTERPRETATION  
Sequencing analyses were performed using SeqScape (V2.5 software; Life 
Technologies), which is a software designed for mutation detection and analysis and 
Single Nucleotide Polymorphisms (SNP) discovery and validation. Variants were 
validated and interpreted using in-house software: GenMol (unpublished) and 
Variobox (University of Aveiro, Aveiro, Portugal) (Gaspar et al., 2013); and external 
on-line resources:  Exome variant server (http://evs.gs.washington.edu/EVS/), which 
is a database that compiles information about the variants already described of the 
Human genome; NCBI dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/), that is a 
database of SNP and multiple small-scale variations that include insertions/deletions, 
microsatellites, and non-polymorphic variants. We also used the Mutalyzer 2.0.beta-
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29 (https://mutalyzer.nl/) that allows checking if the variant description on sequence 
cause changes in translation. 
In order to perform further bioinformatics analysis of the new and rare DNA 
variants found in the analysed genes, we used the free available online tools 
Polyphen-2 (Polymorphism Phenotyping v2; available in 
http://genetics.bwh.harvard.edu/pph2/) that predicts the possible impact of an amino 
acid substitution on the structure and function of a human protein (Adzhubei et al., 
2010); SIFT (‘Sorting Tolerant From Intolerant’ available in http://sift.jcvi.org) that 
predicts, based on the degree of conservation of amino acid residues, whether an 
amino acid substitution affects protein function (Ng and Henikoff, 2003); 
MutationTaster (available in http://doro.charite.de/MutationTaster/), that integrates 
information from different biomedical databases and established analysis tools to 
predict the disease potential of DNA sequence alterations (Schwarz et al., 2010); 
Human Splice Finder (HSF) (available in http://www.umd.be/HSF/), which is a tool that 
predicts the effects of mutations on splicing signals or to identify splicing motifs in any 
human sequence (Desmet et al., 2009). Some of these tools are integrated in Alamut 
Visual V2.4 software (Interactive Biosoftware, Rouen, France). 
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Results 
 
1. GENETICS ANALYSIS BY SANGER SEQUENCING 
Our main goal was to perform a genetic characterization five patients with total 
sperm immotility, in order to find a genetic alteration that may be causing the 
morphological phenotype diagnostic in our patients. Four patients had clinical feature 
compatible with DFS associated with disrupted CPC, RS, DA and doublets; and one 
patient has situs inversus and its axoneme show absence of DA and nexin bridges 
(compatible with KS). Consequently, we initiated our research by studying genes that 
code for proteins involved in these same structures and that are associated with total 
sperm immotility. Accordingly, we selected seven genes: AKAP3 AKAP4, CCDC39, 
CCDC40, DNAH5, DNAI1 and RSPH1. 
Briefly, the genes AKAP3 and AKAP4 code a member of A-kinase anchoring 
proteins (AKAPs), which are involved in the organization of the basic structure and 
assembly of the FS. Mutations are associated with DFS (Baccetti et al., 2005a, 2005b). 
CCDC39 and CCD40 genes are integral components of the DRC and the encoded 
proteins are essential for the assembly of dynein regulatory and IDA complexes. 
Mutations in these genes are associated to PCD and cause disorganization of the Ax, 
including disorganization of the peripheral and outer microtubule doublets, absence or 
shifted CPC, absence of IDA, and anomalies in nexin links and RS (Becker-Heck et al., 
2011; Merveille et al., 2011; Antony et al., 2013). DNAH5 and DNAI1 genes are 
essential to the function of the ODA complex and mutations are related to PCD with 
abnormalities or with the absence of ODA (Pennarun et al., 1999; Olbrich et al., 2002; 
Hornef et al., 2006). Finally, RSPH1 gene codes a RS-head protein that is important for 
the proper building of CPC and RS, since mutations in the RSPH1 leads to an 
abnormal axonemal configuration with CPC and RS defects (Kott et al., 2013; 
Onoufriadis et al., 2014) 
We designed specific primers and optimization was achieved by performing 
several PCR reactions under different conditions, using a DNA sample from a control 
(fertile male). Once the PCR conditions were optimized (see the PCR conditions for 
each exon at Attachment 2), we amplified the patients’ genomic DNA by PCR (Fig. 8). 
Next, all the exonic regions and its intronic boundaries (about 100 bp upstream and 
downstream of each exon) were sequenced by Sanger sequencing method. Due to the 
elevated number of exons, the gene DNAH5 was the only exception. In this gene we 
amplified and sequenced forty exons of the total seventy-nine, that are known to 
harbour a significant number of mutations (Djakow et al., 2012).  
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Figure 8. PCR products after analyses by 2% agarose gel electrophoresis: mix of TAE 1x SeaKem LE Agarose (Lonza), 
and 5µL/100ml of GelRed Nucleic Acid Gel Stain (Biotium). phiX174 DNA BsuRI/HaeIII Marker, ready-to-use (New 
England BioLabs) were used as a marker (M) for sizing. In each picture the gene’s name is listed and in each land are 
the number of the respective exon (For more information about PCR conditions see Attachment 2). 
 
We used the software SeqScape (Life Technologies) for sequencing analysis,  
and we found eight DNA sequence variants in AKAP3 gene, one in AKAP4 gene, ten in 
CCDC39 gene, twenty-six in CCDC40 gene, four in DHAI1 gene, forty-five in DNAH5 
and eight in RSPH1 gene (see Table III).  
Variants were validated and interpreted using in-house software: GenMol 
(unpublished) and Variobox (Gaspar et al., 2013); as well as the external on-line 
resources: (1) Exome variant server (available in http://evs.gs.washington.edu/EVS/), 
(2) NCBI dbSNP (available in http://www.ncbi.nlm.nih.gov/projects/SNP), and (3) 
Mutalyzer 2.0.beta-29 (available in https://mutalyzer.nl/). Variants whose frequency 
within European population (based on Exome variant server and SNP database from 
NCBI) was above 1% were considered as polymorphisms, which is the arbitrary cut-off 
value between a rare variant and polymorphism. 
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Table III. DNA sequence variants identified by Sanger sequencing analysis. 
Gene Patient DNA change 
Protein 
change a 
Previously 
described b 
Frequency* Impact 
AKAP3 
1,2,4 (He) 
3,5 (Ho) 
c.-522C>G - Yes 43.5% Polymorphism 
1,2,4 (He) 
3,5 (Ho) 
c.-245+15A>G - Yes 53.3% Polymorphism 
2, 4 (He) c.-106-96T>G - Yes 19.4% Polymorphism 
1,3,5 (Ho) 
2,4 (He) 
c.353G>A p. Gly118Glu Yes 80.5% Polymorphism 
1,3,5 (Ho) 
2,4 (He) 
c.609G>A p.(=) Yes 77.0% Polymorphism 
1 (Ho) 
2,4 (He) 
c.1026C>T p.(=) Yes 51.2% Polymorphism 
2,4 (He) c.1499T>C p. Ile500Thr Yes 14.6% Polymorphism 
3,5 (Ho) c.2331T>C p.(=) Yes 29.2% Polymorphism 
AKAP4 5 (Hem) c.174+71A>G - Yes 7.8% Polymorphism 
CCDC39 
3 (He) c.233G>A p.Arg78His Yes 0.6% U (Table IV) 
2 (He) c.545A>G p. Thr182Ser Yes 2.6% Polymorphism 
2,3,5 (He) c.738+169G>A - Yes 20.8% Polymorphism 
2,3,5 (He) c.930+95A>G - Yes 50.0% Polymorphism 
5 (He) c.1248A>G p.(=) Yes 17.1% Polymorphism 
3,5 (Ho), 
4 (He) 
c.1359C>T p.(=) Yes 53.1% Polymorphism 
5 (He) c.1528-43A>G - Yes 47.6% Polymorphism 
5 (He) c.2301G>A p.(=) Yes 10.4% Polymorphism 
3 (Ho) 
4 (He) 
c.2397G>A p.(=) Yes 22.2% Polymorphism 
1 (He) c.2540A>G p.Glu847Gly No - U (Table IV) 
CCDC40 
3 (He) c.-49C>A - Yes 8.4% Polymorphism 
1-3, 5 (He) c.29+58C>A - Yes 25.0% Polymorphism 
3 (He) c.30-191G>T - Yes 10.8% Polymorphism 
3 (He) c.30-80G>A - Yes 10.5% Polymorphism 
1-3,5 (Ho)    
4 (He) 
c.207G>C p.(=) Yes 99.0% Polymorphism 
3 (He) c.676+13T>C - Yes 16.0% Polymorphism 
3 (He) c.676+59T>C - Yes 34.3% Polymorphism 
1, 3,5 (He) c.677-4C>G - Yes 21.2% Polymorphism 
3 (He) c.873C>T p.(=) Yes 8.3% Polymorphism 
1, 3,5 (He) c.1159+12C>T p.(=) Yes 18.9% Polymorphism 
1,5 (He) c.1440+136C>T - Yes 26.1% Polymorphism 
5 (He) c.1441-106A>G  Yes 12.3% Polymorphism 
3 (Ho) c.1562+64C>T - Yes 7.7% Polymorphism 
1,3,4 (He) 
2 (Ho) 
c.1890T>G p.(=) Yes 91.9% Polymorphism 
Zygosity: Ho- homozygous; He- heterozygous; Hem- hemizygous (gene locus in cromosome X).   
a-In silico predition; b-Variants previously described in databases (Exome variant server and/or dbSNP from NCBI). The 
variants in blue Bold are the novel variants (variants not described in databases/literature) and the variants listed on 
databases but with a non determined frequency or lower than 1% within European population ((*) based on Exome 
variant server and SNP database from NCBI).  These variants were further analyzed and the results are at table IV. 
 
Abbreviations: c, coding sequence; A, Adenine; G, Guanine; T, Thymine; C, Cytosine; p, protein sequence; Gly, 
Glycine; Glu, Glutamic acid; Ile, Isoleucine; Thr, Threonine; Arg, Arginine; His, Histidine; Ser, Serine; U, variant with 
unknown effect. 
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Table III (continuation) DNA sequence variants identified by Sanger sequencing analysis. 
Gene Patient DNA change 
Protein 
change a 
Previously 
described b 
Frequency* Impact 
CCDC40 
5 (He) c.2255T>C p.Leu752Pro Yes 1.6% Polymorphism 
3 (He) c.2323G>A p.Val775Met Yes 9.9% Polymorphism 
4 (Ho) 
1-3,5 (He) 
c.2450-89A>C - Yes 70.0% Polymorphism 
4 (Ho) 
1-3,5 (He) 
c.2450-53G>A - Yes 65.0% Polymorphism 
3 (He) c.2620-92C>T - No - U (Table IV) 
4 (He) c.2682G>A p.(=) Yes 0.6% U (Table IV) 
3 (He) c.3021+74C>A - Yes 17.8% Polymorphism 
1,2,4,5 (He) c.3030T>C p.(=) Yes 74.8% Polymorphism 
3 (He) c.3210A>G p.(=) Yes 28.0% Polymorphism 
3,5 (He) c.3417A>G p.(=) Yes 37.6% Polymorphism 
3 (He) c.*15T>C - Yes 29.0% Polymorphism 
3 (He) c.*149T>C - Yes 47.0% Polymorphism 
DNAI1 
1(He) c.81+61A>G - Yes 0.3% U (Table IV) 
2,4 (He) c.1003G>A p.Val335Ile Yes 17.7% Polymorphism 
1,3, 5 (Ho) c.1019+42C>T - Yes 24.5% Polymorphism 
2(Ho) 
3,4 (He) 
c.1489+130G>A - Yes 37.2% Polymorphism 
DNAH5 
1,2,5 (He) 
4 (Ho) 
c.661-172A>G - Yes 39.7% Polymorphism 
3 (Ho) c.975+30A>C - Yes 28.2% Polymorphism 
3 (Ho) c.1089+141T>C - Yes 27.0% Polymorphism 
4 (Ho) 
1,2,5 (He) 
c.1197+155G>T - Yes 40.0% Polymorphism 
4 (Ho) 
1,2,5 (He) 
c.1321-53A>G  Yes 43.0% Polymorphism 
4 (Ho) 
1,2,5 (He) 
c.1503T>C p.(=) Yes 89.1% Polymorphism 
3 (Ho) c.1537-102T>A - Yes ND U (Table IV) 
4 (Ho) 
1 (He) 
c.1537-100_ 
1537-99delTT 
- Yes ND U (Table IV) 
3 (Ho) c.1644+90C>A - Yes 30.0% Polymorphism 
3 (Ho) 
4 (He) 
c.1645-196A>G - Yes 31.4% Polymorphism 
4(Ho) 
1,2,5 (He) 
c.1672A>G p.Thr558Ala Yes 42.0% Polymorphism 
1-4(He) c.3835-3delT - Yes 0.1% U (Table IV) 
1-4(He) c.4152A>G p.(=) Yes 45.0% Polymorphism 
1-4 (He) c.4355+60T>C - Yes 50.0% Polymorphism 
1-4 (He) c.4374G>T p.(=) Yes 44.7% Polymorphism 
1-5 (Ho) c.4797-93C>A - Yes 97.0% Polymorphism 
1-4 (He) c.4797-29C>A - Yes 40.3% Polymorphism 
1-4(He) c.4951-92G>A - Yes 50.0% Polymorphism 
1-4(He) c.5114+11T>C - Yes 60.8% Polymorphism 
Zygosity : Ho- homozygous; He- heterozygous; Hem- hemizygous (gene locus in cromosome X).   
a-In silico predition; b-Variants previously described in databases (Exome variant server and/or dbSNP from NCBI). The 
variants in blue Bold the novel variants (variants not described in databases/literature) and the variants listed on 
databases but with a non determined frequency or lower than 1% within European population ((*) based on Exome 
variant server and SNP database from NCBI).  These variants were further analyzed and the results are at table IV. 
 
Abbreviations: c, coding sequence; A, Adenine; G, Guanine; T, Thymine; C, Cytosine; p, protein sequence; Leu, 
Leucine; Pro, Proline; Val, Valine; Met, Methionine; Ile, Isoleucine; Thr, Threonine; Ala, Alanine; U, variant with unknown 
effect; ND, non-defined. 
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Table III (continuation) DNA sequence variants identified by Sanger sequencing analysis. 
Zygosity : Ho- homozygous; He- heterozygous; Hem- hemizygous (gene locus in cromosome X).   
a-In silico predition; b-Variants previously described in databases (Exome variant server and/or dbSNP from NCBI). The 
variants in blue Bold the novel variants (variants not described in databases/literature) and the variants listed on 
databases but with a non determined frequency or lower than 1% within European population ((*) based on Exome 
variant server and SNP database from NCBI).  These variants were further analyzed and the results are at table IV. 
 
Abbreviations: c, coding sequence; A, Adenine; G, Guanine; T, Thymine; C, Cytosine; p, protein sequence; Leu, 
Leucine; Phe, Phenylalanine; Ala, Alanine; Val, Valine; Ile, Isoleucine; Gly, Glycine; Arg, Arginine; U, variant with 
unknown effect; ND, non-defined. 
 
Gene Patient DNA change 
Protein 
change a 
Previously 
described b 
F* Impact 
DNAH5 
1,2,4,5(He) c.5114+22A>T - Yes 50.3% Polymorphism 
1-4(He) c.5114+110A>G - Yes 50.0% Polymorphism 
2 (Ho) 3,4 (He) c.5115-49G>C - Yes 64.6% Polymorphism 
2(Ho) 3,4(He) c.5115-5T>C  Yes 36.5% Polymorphism 
2(Ho) 3,4(He) c.5172C>T p.(=) Yes 35.4% Polymorphism 
2(Ho) 3,4(He) c.5710-58G>A - Yes 50.0% Polymorphism 
3(He) c.5882+133A>G - No - U (Table IV) 
1-3,5 (Ho) c.7408-160G>C - Yes 80.9% Polymorphism 
2 (Ho), 
4 (He) 
c.7408-84_7408-
83delAT 
- Yes ND U (Table IV) 
2 (Ho), 4 (He) c.7408-72C>T - Yes 50.0% Polymorphism 
2 (Ho), 4(He) c.7609+19C>T - Yes 53.8 % Polymorphism 
4,2 (Ho), 
5(He) 
c.8586G>T p.Leu2862Phe Yes 32.6% Polymorphism 
1(Ho) c.10102-29C>T - Yes 26.2% Polymorphism 
1 (Ho) c.10140A>G p.(=) Yes 29.8% Polymorphism 
1 (Ho) c.10282-81delT - Yes ND U (Table IV) 
3 (He) c.10872+84T>C - Yes ND U (Table IV) 
1-3 (Ho), 4 (He) c.11570+35A>G - Yes 57.5% Polymorphism 
3 (He) c.11570+124G>C - No - U (Table IV) 
1-3 (Ho), 4 (He) c.11761+93G>T - Yes 56.6% Polymorphism 
4 (He), 5 (Ho) c.12401C>T p.Ala4134Val Yes 46.2% Polymorphism 
4 (He), 5 (Ho) c.12468A>C p.(=) Yes 42.0% Polymorphism 
5 (Ho), 4 (He) c.12500-194T>G - Yes 40.7% Polymorphism 
5 (Ho), 1,3,4(He) c.12910-11C>T - Yes 40.1% Polymorphism 
2,5 (Ho) c.13348A>G p.Ile4450Val Yes 46.6% Polymorphism 
2,5 (Ho) c.13359A>G p.(=) Yes 48.6% Polymorphism 
2,5 (Ho) c.13491+66T>C - Yes 57.8% Polymorphism 
RSPH1 
1,5 (Ho) 
2,4(He) 
c.-43C>T - Yes 63,97% Polymorphism 
1,2,5 (Ho) 
3,4 He 
c.55-232C>T - Yes 85,00% Polymorphism 
1-5 Ho c.55-189T>C - Yes 90,00% Polymorphism 
1,5 (Ho) 2,4(He) c.55-181C>T - Yes 36,00% Polymorphism 
1,5 (Ho) 2,4(He) c.365+130C>G - Yes 37,00% Polymorphism 
1,5 (Ho) 
2,4(He) 
c.393G>A - Yes 64,72% Polymorphism 
2,3 (He) c.742G>A p.Gly248Arg Yes 23,69% Polymorphism 
1,4 (He) c.*53C>T - Yes 11,69% Polymorphism 
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The majority of the variants found in this initial genetic screening using the 
Sanger sequencing method, were already described in online databases as 
polymorphisms (frequency >1%). Nevertheless, this screening allowed the 
identification of four new DNA variants: one new variant in CCDC39 gene 
(c.2540A>G), one in CCDC40 gene (c.2620-92C>T) and two in DNAH5 gene 
(c.5882+133A>G and c.11570+124G>C) (see Table III); and nine rare variants (that 
is, variants listed on databases but with a non-determined frequency or lower than 1% 
within European population based on Exome variant server and dbSNP from NCBI): 
one in CCDC39 (c.233G>A), one in CCDC40 (c.2682G>A), six in DNAH5 (c.1537-
102T>A, c.1537-100_1537-99delTT, c.3835-3delT, c.7408-84_7408-83delAT, c.10282-
81delT, c.10872+84T>C), and one in DNAI1 (c.81+61A>G) (see Table III). To predict 
the impact of the new and rare variants on patients’ phenotype, further bioinformatics 
analysis were performed, using the freely accessible online tools: Polyphen-2, SIFT, 
HSF and the MutationTaster (see Table IV). 
In patient 1, we observed forty-three polymorphisms, four rare variants 
(DNAH5 gene: c.1537-100_1537-99delTT, c.3835-3delT and c.10282-81delT; and 
DNAI1 gene: c.81+61A>G) and one novel variant in CCDC39 gene.  
The new heterozygous variant c.2540A>G, located in the exon 18 of the 
CCDC39 gene (Fig. 9A), leads to a change on the protein position 847 of glutamic acid 
by glycine. Both bioinformatic tools Polyphen-2 and SIFT1 predict this amino acid 
change as non-pathogenic with a score of 0.17 and 0.066, respectively. By its turn, the 
MutationTaster tool predicts that this variant may be disease causing, with a probability 
of 0.69. According to HSF analysis, there is a marginal increase of the score for a 
exonic splicing enhancer (ESE) motif, more specifically, the alternative splicing factor 
ASF/SF2 (wild type (wt) score: 72.9 and mutant (mt, i.e. the score of the altered 
sequence) score: 82.9). The rare heterozygous variant c.81+61A>G located in intron 2 
of DNAI1 gene (Fig. 9B), increases by 53.56% the score of splice site acceptor (SSA). 
This increase makes the mt score almost equivalent of native score (nt, i.e. normally 
occurring splice site), being the mt score: 82.97 and the nt score: 83.19. This variant is 
also predicted to be pathogenic by MutationTaster bioinformatic tool. Both variants are 
only present in patient 1. The rare variant c.1537-100_1537-99delTT is heterozygous 
in patient one and homozygous in patient 4. The heterozygous variant c.10282-81delT, 
was only detected in patient 1. Both are located at DNAH5 gene and predicted as 
being non-pathogenic, since the bioinformatic tools used did not detected any impact 
(Fig. 9C, D).   
                                               
1 In Polyphen-2 scores higher than 0.5 are considered as damaging and in SIFT scores less than 0.05 are considerate 
deleterious. 
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The last rare variant found in this patient (1), is a heterozygous deletion of a T 
nucleotide three bases before the exon 25 (c.3835-3delT) in DNAH5 gene (Fig. 9E). 
We analyzed this variant by five splice algorithms incorporated in Alamut Visual V2.4 
software: SpliceSiteFinder-like, MaxEntScan, NNSPLICE, GeneSplicer and HSF. With 
exception to NNSPLICE algorithm, which did not detect effect on splice, in the others 
algorithms this deletion is expected to lead to a slight reduction of the score of nt SSA, 
from 92.6 to 89.1 in SpliceSiteFinder-like; 12.8 to 10.4 in MaxEntScan; 11.9 to 9.8 in 
GeneSplicer and 85.85 to 85.29 in HSF. According to MutationTaster, this deletion has 
a probability to be pathogenic (p=1). This variant was also identified in patients 2, 3 and 
4. 
 
Figure 9. Electropherogram of variants detected in patient 1. A. The new heterozygous variant c.2540A>G located 
on CCDC39 gene; B. The variant c.81+61A>G in DNAI1 gene; C. The variant c.1537-100_1537-99delTT detected in 
patient 1 as heterozygous and in patient 4 as homozygous;  D. The heterozygous variant c.10282-81delT also found in 
patient 1; E. The heterozygous deletion c.3835-3delT in DNAH5 gene detected in patient 1 to 4. 
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The patient 2 has fifty DNA variants: forty-eight are polymorphisms and two 
rare variants in DNAH5 gene: c.3835-3delT and c.7408-84_7408-83delAT. The rare 
variant c.7408-84_7408-83delAT is homozygous in patient 2 and heterozygous in 
patient 4 was classified as polymorphism after the bioinformatic analysis. 
The patient 3 presents fifty-nine DNA variants, with fifty-two polymorphisms, 
four rare variants (c.233G>A in CCDC39 gene (Fig. 10A); c.1537-102T>A (Fig. 10B), 
c.3835-3delT (Fig. 9E), and c.10872+84T>C (Fig. 10C) in DNAH5) and three new 
variants (c.2620-92C>T (Fig. 10D) in CCDC40 gene, c.5882+133A>G (Fig. 10E) and 
c.11570+124G>C (Fig. 10F) in DNAH5 gene). The heterozygous variant c.233G>A in 
CCDC39 gene has lower frequency (0.6%) on control population and leads to a change 
of the amino acid arginine by a histidine at position 78, but no pathogenic impact is 
associated to this variant. Likewise, with exception of the variant c.3835-3delT in 
DNAH5 gene, already described, the three new variants and the two rare variants are 
foreseen by bioinformatic tools as polymorphisms. 
 
Figure 10. Electropherogram of the rare variants (A-C) and the novel variants (D-F) detected in patient 3. A. The 
heterozygous variant c.233G>A in CCDC39 gene; B. The homozygous c.1537-102T>A in DNAH5 gene; C. The 
heterozygous c.10872+84T>C in DNAH5 gene; D. The novel heterozygous variant c.2620-92C>T in CCDC40 gene; 
and the two novel heterozygous variants in DNAH5 gene c.5882+133A>G (E) and c.11570+124G>C (F).   
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In patient 4 were identified fifty-one variants: 
forty-seven common variants with higher frequency on 
populations and four rare variants. Three of these four 
rare variants are in DNAH5 gene: c.1537-100_1537-
99delTT (Fig. 9C), c.3835-3delT (Fig. 9E), c.7408-
84_7408-83delAT (Fig. 11), and are also present in 
other patients of this study; the remaining was found in 
CCDC40 gene c.2682G>A, and was detected only in 
this patient. Excluding the variant c.3835-3delT, all 
variants in this patient, are polymorphisms without 
predicted pathogenic impact. 
  
Figure 11. Electropherogram of the heterozygous variant c.7408-84_7408-83delAT detected in patient 2 as 
Homozygous and in patient 4 as heterozygous 
 
 
 
Patient 5, with situs inversus (compatible with KS), has forty-three DNA 
variants with any variant with a predicted pathogenic impact. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.  
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Table IV. Rare and novel DNA sequence variants found by Sanger sequencing and respective 
bioinformatic analysis 
G
e
n
e
 
Patient 
DNA change 
(Location) 
Freq.* 
Protein 
change 
Bioinformatic analysis 
PP- 2 SIFT HSF 
Mutation 
Taster 
C
C
D
C
3
9
 
3 (He) 
c.233G>A 
(exon 3) 
0.56% p.Arg78His 
Benign 
(s=0.00) 
T 
(s=0.28) 
No effect on 
Splice 
P 
(p=0.90) 
1 (He) 
c.2540A>G 
(exon 18) 
New 
variant 
p.Glu847Gly 
Benign 
(s=0.17) 
T 
(s=0.06) 
New ESE 
wt: 72.9 
mt: 82.9 
Dc 
(p=0.69) 
C
C
D
C
4
0
 
4 (He) 
c.2682G>A 
(exon 16) 
0.61% p. (=) - - 
No effect on 
Splice 
P 
(p=0.90) 
3 (He) 
c.2620-92C>T 
(Intron 15) 
New 
variant 
- - - 
No effect on 
Splice 
P (p=0.9) 
D
N
A
H
5
 
3 (Ho) 
c.1537-102T>A 
(Intron11) 
ND - - - 
No effect on 
Splice 
P (p=0.9) 
4 (Ho) 
1 (He) 
c.1537-100_1537-
99delTT 
(Intron 11) 
ND - - - 
No effect on 
Splice 
P (p=0.9) 
1-4 (He) 
c.3835-3delT 
(intron24) 
0.1% - - - 
New SSA 
mt:85.29 
nt:85.85 
Dc (p=1) 
3 (He) 
c.5882+133A>G 
(Intron 35) 
New 
variant 
- - - 
No effect on 
Splice 
P (p=0.9) 
2 (Ho) 
4 (He) 
c.7408-84_7408-
83delAT 
(intron 44) 
ND    
No effect on 
Splice 
P (p=0.9) 
1 (He) 
c.10282-81delT 
(Intron60) 
ND - - - 
No effect on 
Splice 
P (p=0.9) 
3 (He) 
c.10872+84T>C 
(Intron63) 
ND - - - 
No effect on 
Splice 
P (p=0.9) 
3 (He) 
c.11570+124G>C 
(Intron67) 
New 
variant 
- - - 
No effect on 
Splice 
P (p=0.9) 
D
N
A
I1
 
1 (He) 
c.81+61A>G 
(Intron2) 
0.3% - - - 
SSA 
wt: 54.03 
mt: 82.97 
nt:  83.19 
Dc 
(p=0.98) 
Human Splice Finder (HSF): http://www.umd.be/HSF/; PolyPhen-2 (PP-2): http://genetics.bwh.harvard.edu/pph2/; SIFT: 
http://sift.jcvi.org; and the MutationTaster: http://doro.charite.de/MutationTaster/.  
Scores higher than 0.5 in Polyphen are treated as damaging and in SIFT scores less than 0.05 are considered 
deleterious. In MutationTaster a probability (p) closer to 1 indicates a high 'security' of the prediction. *Freq.- Frequency 
within control population (based on Exome variant server and SNP database from NCBI); In blue bold are  the variants 
most promising in terms of predicted pathogenic impact. 
 
Abbreviations: He, Heterozygous; Ho, Homozygous; c, coding sequence; A, Adenine; G, Guanine; T, Thymine; C, 
Cytosine; ND, variant listed in databases but with a non-determined frequency; p, protein sequence; Arg, Arginine; Hist, 
Histidine; Glu, Glutamic acid; Gly, Glycine; Thr, Threonine; Ser, Serine; s, score; p, probability; T, tolerated; D, 
Damaging; P, Polymorphism; Dc, Disease causing; SSA, Splice Site Acceptor; SSD, Splice Site Donor; wt, wild type 
(reference non-mutated score); mt, mutant score (i.e. the score of mutated sequence); nt, native splice site (i.e. normally 
occurring splice site); ESE, Exonic Splice Enhancer. 
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2. GENETICS ANALYSIS BY EXOME SEQUENCING 
2.1.  Exome Sequencing metrics 
 
The results presented in the previous section did not supplied sturdy evidences 
that could explain the phenotype described in these 5 patients, namely in patient 5. 
Considering the complexity of sperm motility and that those patients present 
morphological defects in highly complex structures, with an important role in sperm 
motility, it is conceivable that several genes coding for proteins linked to its assembly, 
composition, function and regulation might be involved. Therefore, we decided to 
analyse all exonic regions (exome) by next-generation exome sequencing (ES) of one 
patient, the patient 5, in order to identify genetic variants that could be underlying this 
phenotype. 
ES of patient 5 (lacking the DA and nexin bridges of its sperm flagellum) was 
performed using Ion AmpliSeq Workflow and analyzed on an Ion Proton sequencer. 
The ES run generated 37,737,917 sequence reads, 99% of which were efficiently 
aligned against the hg19 human reference genome. The exome target regions were on 
average covered 108.9 times, with 93% having a coverage superior to 20%. These 
values are above the defined threshold and thus acceptable for this study. In addition, 
84% of all sequenced bases had a Phred quality scores above Q20, which means that 
the probability of an incorrect base call is 1 in 100 (Ewing and Green, 1998; Ewing et 
al., 1998). In this patient, this analysis identified 49,230 single nucleotide variants 
(SNV) and 3,479 insertions/deletions, which were listed in the Variant Call Format 
(VCF) file of this patient.  
2.1.1. Exome filtering 
The number of protein-coding genes within the human genome is estimated to 
be around 20,000 (Pennisi, 2012), so, as expected, ES generated a huge amount of 
data. After reads alignment and variant calling more than 50,000 DNA sequence 
variants were obtained. Consequently, in order to find a DNA variant that may be 
involved in patient phenotype, we had to filter these variants. As an initial approach we 
filtered the variants matching the autosomal recessive disease model: either 
homozygous or two heterozygous candidate variants for the same gene, using the list 
of 67 candidate genes previously reported in literature as being associated to sperm 
immotility due to flagellar abnormalities. The recessive disease model was chosen 
because patient 5 has no family history of infertility and the clinical features found were 
compatible with KS (PCD), which was consistently described in the literature as having 
an autosomal recessive inheritance pattern (Boon et al., 2013; Lie and Ferkol, 2007). 
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The GEMINI database framework (Paila et al., 2013) was used for annotation and 
prioritization of variants. From this filters we narrowed down our analysis to 258 
sequence variants in ten different genes. In addition, we also verified if, besides the 
genes previously selected, other loci could be also involved in the patient’s phenotype. 
For that, we used the Ion Reporter™ Software (Life technologies) to filter the rare 
variants by Gene Ontology (that covers three domains: cellular component, molecular 
function and biological process), using the key words: flagellar motility, sperm motility, 
axoneme and dynein. Using this new filter we selected more 46 DNA variants. In total, 
with the application of both approaches we reduced from 52709 variants to 304 
variants. Our initial filtering steps gave priority to rare variants located in exonic regions 
and those placed within intronic regions near exons (8bp from exon). For that reason, 
167 intronic variants (more than 8bp away from the exon) and 53 variants with a 
frequency above 1% were excluded. Of the remaining 84 variants, 51 are synonymous, 
30 are missense and 3 are frame-shift. The 51 synonymous variants were evaluated 
using bioinformatic tools and excluded for further analysis since no effects on splicing 
were predicted. Seventeen of the 30 missense variants belong to the gene HYDIN 
located at chromosome 16q22.2, which has an identical paralogous segment inserted 
on chromosome 1q21.1 (Doggett et al., 2006). Consequently, we suspected that the 
high number of novel variants found in this gene may be attributed to this duplication. 
Our suspicion was also shared by Berg et al.  (Berg et al., 2011), which add further 
support to our supposition. As result, these changes were excluded from further 
analysis. The remaining 16 variants were visually inspected on the BAM file 
GenomeBrowse version 2.0.2. (Golden Helix). Nine variants were considered 
sequencing artifacts and seven were selected (Fig. 12) for Sanger sequencing 
confirmation.  
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Figure 12. Alignments of the selected variants after the visual inspection on the BAM file through 
GenomeBrowse version 2.0.2. A. Variant c.104G>C in CCDC103; B. c.262_263delCC in INSL6; C. c.3167A>T in 
DNAH6; D.  c.7895C>T in DNAH10; E. c.828C>G in GAS8; F. c.4445G>T in SPAG17 ; G. c.8delC in MYCBPAP gene. 
The light blue and green lines represent the forward and revers strain, respectively. Citosine (C), Guanine (G), Timine 
(T) and Adenine nucleotides are the bars yellow, green, blue and red respectively. Deletions are presented as pink bars. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
G 
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2.2. Exome results 
Of the seven variants selected from ES to confirm by Sanger sequencing, six 
were confirmed as true variants and are present only in patient 5. The variant in 
MYCBPAP gene, c.8delC, proved to be a sequence artifact. These six variants include 
five missense changes (CCDC103:c.104G>C, p.Arg35Pro; DNAH10:c.7895C>T, 
p.Thr2632Met; DNAH6:c.3167A>T, p.Asp1056Val; GAS8:c.828C>G, p.Asn276Lys; 
and SPAG17:c.4445G>T, p.Arg1482Leu) and one frame-shift deletion (INSL6: 
c.262_263delCC). The variant in DNAH10 gene is the only variant of these six that 
were already listed in genetic variant databases available online, but with a reduce 
frequency of 0.0013. All the others are reported for the first time. Table V resumes the 
bioinformatic analysis of the six variants selected and figure 13 shows the 
electropherograms after the Sanguer sequencing. 
 
Figure 13. Electropherograms of the variants selected from exome sequencing and after Sanger sequencing 
confirmation. With the exception of c. 7895C>T variant located in DNAH10, whose frequency on control 
population is 0.0013, all are reported for the first time. 
FCUP  
Results 
55 
 
 
 
The novel homozygous variant c.104G>C located in exon 2 of CCDC103 gene 
(NM_001258398.1; 17q21.31) lead to a change of a conserved amino-acid arginine by 
a proline at position 35 (Fig. 14). In three different bioinformatic software’s this variant 
is predicted as potentially pathogenic, with the scores of 0 in SIFT, and 0.99 in 
Polyphen-2 and MutationTaster. 
The heterozygous deletion of two cytosine (C) nucleotides at position 262 of 
exon 1 of the INSL6 gene (NM_007179.2; 9p24), change the open read frame and may 
result in a completely different translation and originate a shorter polypeptide 
(p.Pro88Glyfs*27). MutationTaster evaluates this variant as disease causing (p=1). 
Consequently, is assumed to have a pathogenic impact. 
We identified variants in two different genes that code for proteins of dynein HC: 
DNAH10 gene (NM_207437.3; 12q24.31) and DNAH6 gene (NM_001370.1; 2p11.2). 
According to Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) 
(Franceschini et al., 2013), these two genes may interact with a score of 0.540 (scores 
closer to 1 mean a highest confidence on result).  
The heterozygous missense variant c.7895C>T in exon 47 of DNAH10 gene, is 
the only of this six variants that is not reported here by the first time, but its frequency is 
very low (0.13%). This together with the fact that this gene is part of DA HC, led us to 
consider this variant for further analysis. This variant lead to a change of amino acid 
threonine by methionine at protein position 2632. This amino acid is much conserved 
and this alteration is predicted as being damaging by SIFT (s=0.02) and Polyphen-2 
(s= 0.98) and as disease causing (p=0.99) by MutationTaster. The other missense 
variant c.3167A>T in exon 20 of DNAH6 gene is also heterozygous and cause a 
change in another conserved amino acid at protein position 1056, an acidic polar with a 
negative charge, the aspartic acid, by a nonpolar and neutral amino acid, the valine. 
The three bioinformatic tools predicted that may have a pathogenic impact, with scores 
of 0.00, 0.98 and 0.99 respectively by SIFT, Polyphen-2 and MutationTaster.  
The two last missense heterozygous variants c.828C>G and c.4445G>T, are in 
exon 7 of GAS8 (NM_001481.2; 16q24.3) and exon 31 of SPAG17 (NM_206996.2; 
1p12), respectively. The change of the polar and neutral amino acid asparagine by the 
basic and positive amino acid lysine at position 276, is predicted by MutationTaster and 
by Polyphen-2 (p=0.99 and s=0.72, respectively) as being possibly pathogenic, 
however according to SIFT (s=0.38) no pathogenic impact is expected for this variant.   
For the variant c.4445G>T no pathogenic impact is predicted, despite the change of an 
arginine to a leucine at position 1482. 
 
56 
FCUP 
Mutation analysis of genes involved in sperm motility: A study on patients with total sperm immotility 
 
 
Table V. List of the variants detected by exome sequencing and its respective 
bioinformatic analysis. 
 
 
SIFT: http://sift.jcvi.org; PolyPhen-2: http://genetics.bwh.harvard.edu/pph2/ and the MutationTaster: 
http://doro.charite.de/MutationTaster/.  
Scores higher than 0.5 in Polyphen are treated as damaging and in SIFT scores less than 0.05 are considered 
deleterious. In MutationTaster a probability (p) closer to 1 indicates a high 'security' of the prediction.  Freq.*- Frequency 
within control population (based on Exome variant server (http://evs.gs.washington.edu) and SNP database from NCBI 
(http://www.ncbi.nlm.nih.gov/snp)); In bold blue are the ones most promising in terms of predicted pathogenic impact. 
Abbreviators: a, in silico prediction; D, Damaging; s, score; p, probability; PCD, primary ciliary dyskinesia; na, non-
applicable.  
 
 
 
 
 
 
Figure 14. Multiple sequence alignment of the region of the CCDC103 protein sequence altered in the variant 
p.Arg35Pro, showing the high degree of conservation of this region. Adapted from Alamut Visual V2.4 Software. 
 
 
 
Gene 
DNA change/ 
Zigoty 
Protein 
changea 
Freq.* SIFT PolyPhen2 
Mutation 
Taster 
Phenotype 
associated 
CCDC103 
c.104G>C 
Homozygous 
p.Arg35Pro 
New 
variant 
D (s=0) D (s= 0.99) 
Disease 
Causing 
(p=0.99) 
PCD 
(Panizzi et al., 
2012) 
INSL6 
c.262_263delCC 
Heterozygous 
p.Pro88Glyfs*27 
New 
variant 
na na 
Disease 
Causing 
(p=1) 
Spermatogenic 
Failure 
(Lok et al., 2000; 
Chen et al., 2011) 
DNAH10 
c.7895C>T 
Heterozygous 
p.Thr2632Met 0.13% 
D 
(s=0.02) 
D (s= 0.98) 
Disease 
Causing 
(p=0.99) 
no phenotype 
associated 
DNAH6 
c.3167A>T 
Heterozygous 
p.Asp1056Val 
New 
variant 
D (s=0) D (s= 0.98) 
Disease 
Causing 
(p=0.99) 
no phenotype 
associated 
GAS8 
c.828C>G 
Heterozygous 
p.Asn276Lys 
New 
variant 
Tolerated 
(s=0,38) 
Possibly 
Damaging 
(s= 0.72) 
Disease 
Causing 
(p=0.99) 
Sperm 
immotility/PCD 
(Yeh et al., 2002; 
Horani et al., 2013) 
SPAG17 
c.4445G>T 
Heterozygous 
p.Arg1482Leu 
New 
variant 
Tolerated 
(s=0,23) 
Bening 
(s=0.005) 
P (p=0.9) 
PCD 
(Teves et al., 
2013) 
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Discussion 
The goal of this work was to genetically characterize five patients from two 
Portuguese assisted reproductive centres in order find a genetically explanation to the 
sperm immotility of our patients. In four unrelated subjects were diagnostic with DFS 
(n=4, patient 1 to 4) and one have clinical features compatible Kartagener Syndrome 
(KS, a case of PCD) (n=1, patient 5). To achieve  this we initially selected seven genes 
associated to anomalies in sperm flagellum, namely in FS (AKAP3 and AKAP4 genes) 
and Ax (CCDC39, CCDC40, DNAI, DNAH5 and RSPH1 genes), and analysed all 
exonic regions of selected genes in all subjects by Sanger Sequencing. Next, we also 
performed whole-exome analysis using next-generation sequencing (NGS) technology 
in the KS patient with situs inversus (patient 5).  
With this work we identified nine new DNA sequence variants (c.2540A>G in 
CCDC39, c.2620-92C>T in CCDC40, c.104G>C in CCDC103, c. 5882+133A>G and 
c.11570+124G>A in DNAH5, c.3167A>T in DNAH6, c.828C>G in GAS8, 
c.262_263delCC in INSL6 and c.4445G>T in SPAG17) and ten rare variants 
(c.233G>A in CCDC39; c.2682G>A in CCDC40; c.1537-102T>A, c.1537-100_1537-
99delTT, c.3835-3delT, c.7408-84_7408-83delAT , c.10282-81delT, c.10872+84T>C in 
DNAH5; c.7895C>T in DNAH10 and c.81+61A>G in DNAI1).  
The variants c.2540A>G in CCDC39, c.104G>C in CCDC103, c.3167A>T in 
DNAH6, c.7895C>T in DNAH10 and c.262_263delCC in INSL6 are predicted to be 
deleterious.   
The novel heterozygous variant c.2540A>G in CCDC39 gene was found in 
patient 1. This patient was characterized has having hyperplastic and hypertrophic FS 
and sperm Ax without the CPC and the RS, and microtubule doublets were 
disorganized. Besides changing the amino acid glutamic-acid to glycine at position 847, 
according to Human Splice Finder (HSF), its variant may slightly increase the score of 
an alternative splice factor ASF/SF2. This factor is required for spliceosome assembly 
and are able to influence selection of alternative splice sites (Shepard and Hertel, 
2009; Zhou and Fu, 2013). A previous report showed that ASF/SF2 intervenes in the 
maintenance of genomic stability and preventing DNA fragmentation by protecting cells 
from the deleterious effects of transcription itself (Li and Manley, 2005). Consequently, 
it could have an impact on normal splicing and thus modify the protein function. This 
same patient also presents a heterozygous DNA variant c.81+61A>G in DNAI1 gene 
that is predicted to make the mt SSA score almost equivalent to the nt (mt: 82.97; nt: 
83.19). This increase could lead to a competition for the splice site and eventually have 
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an impact at the mRNA level. Both genes are essential components of DA and 
important for sperm motility. CCDC39 gene is located at chromosome 3q26.33 and is 
strongly expressed in tissues rich in ciliated cells, namely in nasal brushings, lungs and 
testis (Merveille et al., 2011). Previous reports state that CCDC39 is an axonemal 
protein whose absence results in disorganization of the peripheral microtubule 
doublets, absent or shifted CPC, partial or complete loss of IDA and the RS, thus 
causing Ax disorganization and dyskinetic beating (Merveille et al., 2011; Antony et al., 
2013). DNAI1, located at chromosome 9p13.3, encodes an axonemal dynein 
intermediate chain (IC) and is highly expressed in trachea and testis. This gene is 
associated to sperm immotility due to the absence of ODA (Pennarun et al., 1999). 
Despite their important roles on sperm immotility and the predicted bioinformatic impact 
of these variants, these are unlike to explain the patient’s phenotype considering that 
they are heterozygous. Further experimentally studies are required to conclude about 
the real pathogenicity of both variants. 
The heterozygous deletion of a T in DNAH5 gene (c.3835-3delT) was present 
in four patients (patient 1 to 4) whose analyses of transmission electronic microscopy 
revealed hyperplastic and hypertrophic FS. Despite being present in four of five 
patients, this variant has a very low frequency (< 0.1%) within a large control sample. 
Bioinformatic analysis for this variant suggested a possible splicing effect but there was 
only a marginal reduction of the score of the nt SSA. It is also considered as likely to 
cause disease by MutationTaster. Here again, based on this data alone it is not 
possible to classify this variant as a polymorphism, neither to conclude about its 
pathogenic impact. Consequently, and considering its high frequency within our 
patients, this variant requires further studies.  
There are some inconsistencies between the ultrastructural spermatic changes 
found in the patients and the feature previously reported linked to DNAH5 mutations. 
The gene DNAH5, located at chromosome 5p15.2, encodes for an axonemal HC 
dynein protein that is strongly expressed in lung and kidney and weakly expressed in 
brain, heart, and testis (Olbrich et al., 2002). It is the most mutated gene in PCD 
patients that exhibit ODA defects (Hornef et al., 2006; Djakow et al., 2012). However, 
only one of the four patients lacked DA in its sperm Ax. We might speculate if a 
heterozygous change in this gene, may not be sufficient to cause the absence of DA 
but can have an effect, together with other genetic modifiers, on the flagellar 
movement. Two previous works detected mutations in another gene, DNAH11 that 
encodes for an axonemal HC dynein protein in patients with abnormal ciliary beating 
pattern but with a typical axonemal ultrastructure (Schwabe et al., 2008; Knowles et al., 
2012). Nevertheless, it is important to consider that the respiratory tract of our patients 
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was not clinically evaluated, and that sperm and respiratory cells carrying the same 
mutations may have distinct phenotypes regarding the DA (Fliegauf et al., 2005).  
In this DNAH5 gene, we were initially expecting to find pathogenic variants, 
particularly on patients 3 and 5 whose sperm Ax lack DA. However, as previously 
stated DNAH5 gene is a large gene with seventy nine exons and only half of these 
were sequenced in this work. The majority of the reported mutations were described in 
the selected exons (Djakow et al., 2012). However, we cannot exclude the hypotheses 
that the remaining thirty-nine exons might carry variants that could be involved in the 
phenotype. 
We also raised the hypothesis that mutations in AKAP3 and AKAP4 genes, 
most abundant structural proteins of the FS and with important roles in sperm motility, 
could explain the phenotypes of this patients (1 to 4),  (Brown et al., 2003; Eddy et al., 
2003). This possibility was based on several previous observations. Miki and 
collaborators, demonstrated that male mice lacking AKAP4 protein were infertile due to 
reduced sperm motility and by development anomalies in FS (Miki et al., 2002). 
Baccetti et al detected deletions in AKAP3/4 binding regions and a moderate diffuse 
signal after immunostaining for human AKAP4 protein in DFS patients (Baccetti et al., 
2005a, 2005b). However, our results, in a limited number of patients, did not support 
the hypotheses that AKAP3 and AKAP4 are major genetic causes of DFS. Our results 
are in agreement with Turner et al that did not detected mutations in these genes as 
well (Turner et al., 2001). Moretti et al  studied a group of patients with high presence 
of sperm necrosis and total immotility where AKAP4 protein or tubulin labelling was 
absent, but similarly, they did not detected gene mutations (Moretti et al., 2007). This 
demonstrates that the role of AKAP3/4 is still unclear and leads us to postulate that 
DFS is a multigenic trait that may be caused by mutations in (several) other genes yet 
to be identified related to FS function and/or assemble. FS assembly proceeds from 
distal to proximal along the Ax and occurs during the spermiogenesis, at acrosomal 
phase. Thus, the FS defects could be caused by mutations in spermiogenic genes 
related to the FS, for instance, genes related to formation, transport or attachment of 
the longitudinal columns or in genes that command the development of the flagellum. 
Further studies about molecular elements involved in human FS development and 
structure as well as studies about mechanisms of intraflagellar transport of cell factors 
necessary for the FS and flagellum formation, need to be done to fully understand the 
genetic cause of the DFS. 
Regarding patient 5, who presented situs inversus, severe respiratory 
symptoms (nasal polyps, chronic sinusitis, rhinitis and bronchitis) and its sperm 
flagellum lacked the DA and nexin bridges, no candidate DNA variants were detected 
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in selected genes that may justify the patient’s phenotype. This was not anticipated by 
our group given the function of selected genes and the patient’s phenotype. On the 
other hand, considering the complexity of the sperm Ax structures and of the sperm 
motility process, is likely that several genes are involved in formation/ assembly/ 
transport of Ax structures and consequently several variants in multiple genes can give 
rise to this phenotype. Hence, to increase our knowledge about which are these genes, 
we decided to perform an ES analysis. From the six variants confirmed by Sanger 
sequencing, only the missense variant p.Arg1482Leu in SPAG17, were predicted to be 
a polymorphism by all bioinformatic software.  
The GAS8 gene (originally designated GAS11), located at chromosome 
16q24.3, is expressed predominantly in testis. The heterozygous variant c.828C>G, is 
a missense variant that leads to an amino acid change at protein position 276 
(p.Asn276Lys) and occurs in a growth-arrest specific microtubule binding domain 
(pfam accession number (http://pfam.xfam.org/:13851) that is a highly conserved 
central region among metazoan. Two bioinformatic tools predict as being possibly 
pathogenic (see Table V). Immunohistochemical analyses showed that GAS8 is 
present in spermatids, in the tail of the spermatids and also in flagella of mature 
spermatozoa (Yeh et al., 2002). GAS8 may be associated with tail maturation and may 
be involved in the attachment of the dynein regulatory complex (DRC) to microtubules 
(Yeh et al., 2002; Bekker et al., 2007). Studies in Zebrafish lines demonstrated that 
GAS8 is required for normal motility of cilia (Colantonio et al., 2008). Altogether, these 
facts suggest that GAS8 might be important for motility. 
The heterozygous missense variants p.Thr2632Met in DNAH10 gene and 
p.Asp1056Val in DNAH6 gene are both located in genes encoding for dynein HC 
protein. Each HC comprises2 an N-terminal domain; a C-terminal segment, that 
includes a highly conserved central section with six AAA modules (the modules 1 to 4 
have P-loop nucleotide binding motifs (P1-4)); and a microtubule-binding domain (Kim, 
2000). According to NCBI Conserved Domain Database 
(http://www.ncbi.nlm.nih.gov/cdd/), the amino acid change in DNAH10 protein at 
position 2632, occurs in the third AAA module (an AAA_7 super family domain; P3), 
which is a highly conserved region and its P-loop includes an ATP binding site. 
Silvanovich et al hypothesized that in cytoplasmic dynein, the P3 function is required 
for the ATP-induced release of the dynein complex from microtubules and showed that 
mutation of P3 appears to block the ATP binding and hydrolysis at P-loop 1, which, if it 
is true also for axonemal dyneins, could ultimately affect the motility (Silvanovich et al., 
                                               
2 See introduction for more detailes 
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2003). Relatively to the amino acid change in DNAH6 protein at 1056 position, it is 
localized in the N-terminal region, which is important to specify the intracellular location 
of the dynein isoform by the binding of accessory proteins to this domain and is 
required for assembly of the dynein particle (Asai and Koonce, 2001). As far as we 
know, this is the first time that these two dynein HC genes are associated to sperm 
motility in Humans. However, RNAi knockdown of DNAH10 in Trypanosoma brucei 
leads to flagellum immotility and to structural defects in the Ax (Zukas et al., 2012). 
Despite the role of that these genes may play in DA, considering the autosomal 
recessive inheritance pattern of the KS, is questionable that these two heterozygous 
variants are sufficient to cause the totally lack of DA. Unless that the predicted 
interaction of these two proteins, as suggested by STRING, has some biological 
meaning.  
In CCDC103 gene, the conversion of an arginine by a proline at protein position 
35, caused by the homozygous variant c.104G>C, according to Polyphen-2 and SIFT 
is predicted to generate a protein damage with scores of 0.99 and 0, respectively. 
MutationTaster also predicted that this protein may cause a disease phenotype 
(p=0.99). Multiple sequence alignment of the protein sequences shows that the 
arginine residue is highly conserved (Fig. 14). The CCDC103 gene is a DA attachment 
factor, whose mutations cause absence or severe defects in the IDA and/or ODA in 
PCD patients with situs inversus and paralysis of respiratory cell cilia beat (Panizzi et 
al., 2012). Altogether, the available data suggests that this variant may be responsible 
for the lack of DA in our patient. Panizzi et al did not focus their study in fertility; neither 
had we found any study that associated sperm immotility to DNA sequence variants in 
this gene. As result, this is the first report of a DNA sequence variant in CCDC103 
gene that might be associated to sperm motility in a patient with total sperm immotility, 
absence of DA and situs inversus.  
The INSL6 gene, located at chromosome 9p24, belong to the relaxin family of 
peptide hormones whose members are involved in several reproductive functions 
(Anand-Ivell et al., 2013; Anand-Ivell and Ivell, 2014) and is predominantly expressed 
in male germ cells (Lok et al., 2000). Burnicka-Turek et al using Insl6-null mice 
demonstrated that Insl6 deficiency causes an arrest of spermatogenesis at late stages 
of meiotic prophase, leading to a reduction of the spermatozoa production and causing 
immotility to the ones that are actually produced. Hence, they proposed that INSL6 
gene is required for normal spermatogenesis (Burnicka-Turek et al., 2009). Chen and 
collaborators found a heterozygous missense mutation in exon 2 of INSL6 that 
changed the arginine residue at position 171 to histidine, in one patient with 
spermatogenic failure. In their work, they proposed that this mutation might be 
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responsible for its phenotype, due to the probable disruption of the processing of INSL6 
pro-hormone (Chen et al., 2011). We found a heterozygous deletion of two C 
nucleotides in cDNA position 262_263, that disrupts the reading frame and may affect 
the protein function. Thus, ultimately, according to previous reports about its function, 
this deletion is likely to disrupt the spermatogenesis and hence contributes to sperm 
immotility of our patient. 
Overall, the homozygous variant c.104G>C of CCDC103 gene and the frame-
shift variant c.262_263delCC in INSL6 gene, were both considered as the most 
plausible causes for the absence of DA and for the total sperm immotility in patient 5.  
Here again, to understand the real impact of all predicted pathogenic variants, 
detected in this study, and as a proposal of future work, further studies, namely 
expression studies, for instance study the RNA to analyse if the variants indeed affect 
the splicing and thus altered the normal expression of the mRNA; and also studies 
using knock-out animal models, need to be carried out.  
Unfortunately, patient’s RNA was inaccessible to continue our investigation, and 
thus considered beyond the scope of this work. However, RNA samples obtained from 
sperm or testicular cells are important to provide further evidences about the effect 
produced by these variants and clarify about its impact. RNA studies performed in 
fertile and infertile males have already proven to be useful to identify differentially 
expressed genes (Carreau et al, 2007; Garrido et al, 2009; Hamatani, 2012). 
Nevertheless, this is not a simple analysis, since sperm contains very limited amounts 
of messenger RNA (mRNA), roughly estimated to contain about 0.015 pg of mRNA. 
Spermatozoon is now considered as a dynamic cell that, under specific conditions, 
RNA transcriptional changes occur in response to environmental stimulate and 
epigenetic alterations (Miller et al., 2005; Miller and Ostermeier, 2006).  
The knock-out animal models could be a good alternative to (or combined with) 
RNA analysis to determine the impact of these variants. Mouse models have long been 
important tools in medical research and there are a number of reports that used them 
to study genes involved in male infertility (Escalier, 2001, 2006; Tamowski et al., 2010). 
Also Chlamydomonas reinhardtii has proved to be an excellent model for studying the 
molecular components of Ax and to the identification of genes involved in axonemal 
assembly (Inaba, 2007, 2011). 
Besides the lack of these experimental studies, we also consider relevant to 
study the information about the patient’s family history, which could help drawing a 
pedigree chart and also stablish the disease’s inheritance pattern. Samples from 
parents would also be very helpful to understand if a particular genetic variant was 
inherited from their parents or arose as de novo. Depending on the patient’s pedigree, 
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the interpretation about the pathogenicity of the variants would have been more 
accurate.   
In this work we used two different sequencing technologies: the automated 
Sanger sequencing and NGS. The automated Sanger sequencing method is based on 
the original method developed by Frederick Sanger during the 1970s. This approach 
generates DNA fragments labelled with a fluorescent dye, and then DNA sequencers 
carry out capillary electrophoresis for size separation, detection of dye fluorescence, in 
order to create electropherograms. This method had dominated Genetics for the last 
two decades and is still considered the “gold-standard” for genetic testing and also 
used to confirm NGS results, since it is highly accurate. Nevertheless, Sanger 
sequencing has some limitations such as its costs, time consumption and the low 
throughput, when comparing with NGS, in which many genes are analysed at once.  
In order to increase our knowledge about genetics of sperm immotility and 
considering the genetic heterogeneity of PCD and the highly complexity of FSD and 
sperm motility, that are probably inherited as a complex multigenic traits we decided to 
use the NGS technologies. It generates an enormous amount of data in a more cost-
effective and faster way (Metzker, 2010) than Sanger sequencing. Among NGS 
technologies available, ES has already demonstrated great potential to identify genes 
associated to Mendelian disease, as is an efficient strategy to selectively sequence the 
entire coding regions of the genome (Bamshad et al., 2011, Ku et al., 2012a). 
Comparing with other NGS technologies, such as Whole Genome Sequencing (WGS), 
ES is currently the most effective technical approach available since it reduces the 
amount of data, therefore making the bioinformatic analysis easier, as well as, being 
less expensive (Bamshad et al., 2011; Parla et al., 2011). ES has already contributed 
to the identification of new genes involved in PCD (Horani et al., 2012; Knowles et al., 
2013; Kott et al., 2013; Onoufriadis et al., 2014). Nevertheless, ES use still faces some 
limitations, such the considerable rate of false-positive variants because of 
mismapped/aligned reads or sequencing errors (Bamshad et al., 2011). In addition, ES 
only covers the exonic regions, meaning that approximately 99% of the human genome 
is not included in this assay. Thereby ES is not able to identify the structural and non-
coding variants that may be associated with the disease. It is conceivable that, with the 
reduction of costs and the development of more powerfully and robust bioinformatic 
tools, WGS may eventually gain insights and become a standard approach for these 
studies.  
As a future work, it was already discussed that would be important to perform 
further experimental analysis and analyse the patient’s familiy. In addition, it will be 
important to further clinically characterize these patients and perform ES analysis on 
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the remaining four. Moreover, it would be also interesting to study the transcriptome of 
sperm or testis cells, for example using RNA-Seq (RNA sequencing method based on 
NGS). It is known that human genome is composed of regulatory regions that are not 
part of the exome and mutations in those regions (e.g., promoter) can potentially affect 
protein production and consequently their function. RNA-seq allows the discovery of 
new transcripts, the study of alternative splicing patterns, the detection of fusion 
transcripts and allele-specific expression analysis. However, it should be done only as 
a complementary analysis since the transcriptome is very dynamic changing with time 
and tissue/cell type depending on the conditions. Transcriptome sequencing is cheaper 
and avoids some technical limitations of ES such as enrichment steps, but does not 
detect variants in non-transcribed genes (Ku et al., 2012b) or mutations causing non-
sense mediated decay. Consequently, and contrasting with ES, it is not widely used to 
detect variants underlying Mendelian disorders. 
The knowledge of the genetic basis of sperm immotility is important to alert the 
patients that need to use Assisted Reproductive techniques of risks of transmitting the 
mutation to its offspring. Moreover, understanding which genes are involved in sperm 
motility, how they are correlated as well as how exactly protein works and how these 
variants may affect its function, is essential to plan and develop, in the future, a gene 
therapy. Several advances have been done to develop genetic therapies for diseases 
caused by single-gene defects, such as Cystic Fibrosis (Ikpa et al., 2014), haemophilia 
(High et al., 2014), muscular dystrophy (Sumner, 2006), and sickle cell anemia 
(Frenette and Atweh, 2007). However, in more complex genetic disease, we are still in 
the beginning and much work still yet to be done.  
 
To conclude, our study typifies the difficulties to study clinical and genetically 
heterogeneous diseases (namely DFS and PCD) or complex phenotypical traits (such 
as sperm immotility) by conventional (Sanger) sequencing. Sperm immotility may be 
caused by defects in multiple genes and/or by the interaction of multiple variants 
located in different genes. In our study, nine new DNA sequence variants were 
identified, with two in particular being considered the most likely genetic defects that 
explain the phenotype of the patient with situs inversus and lack of DA. Finally, this 
dissertation corroborates that ES is the most efficient approach to study these 
pathologies, allowing further knowledge about the genetic causes of sperm immotility 
and infertility.  
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ATTACHMENT 1 
In this attachment are described the methodology applied by Sousa et al. 
(2014) to perform the transmission electronic analyses of the immotile sperm of the five 
patients selected for the present genetic study and its main results.  
Methodology  
1. Selection of patients 
Five patients, from Hospital Centre of Vila Nova de Gaia (CHVNG) (n = 4) and 
Centre of Reproductive Genetics Prof. Alberto Barros (CGR) (n=1) were selected 
based on total absence of sperm motility by semen analysis and ultrastructural 
confirmation. 
2. Transmission electron microscopy   
Semen samples were processed for transmission electron microscopy (TEM) at 
the Dept. of Microscopy, Lab. of Cell Biology, Institute of Biomedical Sciences Abel 
Salazar (ICBAS), University of Porto.  
Samples were fixed with Karnovsky (2.5% glutaraldehyde, 4% 
paraphormaldehyde, 0.15 M sodium cacodylate buffer) (Sigma-Aldrish, St. Louis, USA; 
Merck, Darnstradt, Germany) for 30 min at room temperature and then for 2 h at 4ºC, 
washed in 0.15 M sodium cacodylate buffer, pH 7.3 (Merck), post-fixed with 2% 
osmium tetraoxide (Merck) in buffer for 2h at 4°C, washed in buffer (10 min), serially 
dehydrated in ethanol (Panreac, Barcelone, Spain), equilibrated with propylene oxide 
(Merck) and embedded in Epon (Sigma). Semithin and ultrathin sections were 
prepared with a diamond knife (Diatome, Hatfield, Switzerland) in a LKB 
ultramicrotome (Leika Microssystems, Weltzlar, Germany). Ultrathin sections collected 
on 200 mesh formvar carbon-coated copper grids (Taab, Berks, England), stained with 
3 % aqueous uranyl acetate (20 min) (BDH, Poole, England) and Reynolds lead citrate 
(10 min) (Merck). Ultrathin sections were observed in a JEOL 100XII transmission 
electron microscope (JEOL, Tokyo, Japan) operated at 60 Kv.  
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Main Results  
Four of the five patients of this study (patient 1-4) were previously characterized 
as having clinical features compatible with dysplasia of fibrous sheath (DFS).  
 The patient 1 (Fig. 15), had a reduced midpiece (MP) with a few dispersed 
mitochondria that presented a light appearance. This patient lack its annulus (An), thus 
the MP was continuous with the principal piece (PP) with hypertrophy, hyperplasia and 
disruption of fibrous sheath (FS) and with FS invading the MP. The axoneme (Ax) 
contains the nine microtubules doublets and the dynein arms (DA) but lacks the central 
pair complex (CPC) and the radial spokes (RS), thus showing a 9+0 pattern.  
 
Figure 15. Ultrastructure of sperm from Patient 1. A. Longitudinal section of the sperm showing the head with a 
regular nucleus (N) and a displaced acrosomal vesicle (AV). At the midpiece (MP) is possible to see that mitochondria 
(m) are scarce and that the dysplastic fibrous sheath (FS) invades the MP region. No annulus material (arrows) is seen 
to distinguish the MP to the principal piece (PP); B. The basal plate (BP), centriole (Ce), striated columns (SC) and 
outer dense fibres (ODF) appear normal in the neck region, whereas mitochondria (m) display pale areas; C. The 
axoneme at the proximal PP, in which dynein arms (white arrowheads) are present but the central pair complex and the 
radial spokes (*) are absent. D. The axoneme at the distal PP, also without the central pair complex and radial spokes 
(*) and with microtubule doublet disorganization (arrow). Images provided by Professor Mário Sousa. 
 
The patient 2 (Fig. 16) show an enlarged MP, due to the presence of extra 
cytoplasm, and contained aggregated and misaligned mitochondria. The An material 
was present. At PP the FS material forms a unilateral longitudinal row and was seen a 
disorganized FS with a mild hypertrophy and hyperplasia. Any normal Ax were find, 
and most of them presenting a variable reduced number of microtubule doublets, RS 
and ODF, with presence of the CPC. 
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Figure 16. Ultrastructure of sperm from Patient 2 A. Longitudinal section of the sperm showing an irregular nucleus 
(N) and a displaced acrosomal vesicle (AV). The basal plate (BP), centriole (Ce), striated columns (SC) and outer dense 
fibers (ODF) show a typical structure. The apical region of the midpiece (MP) is enlarged with aggregates of pale 
mitochondria (m); B The annulus (arrows) is present and the apical region of the principal piece presents an unilateral 
row of FS followed by a dysplastic FS; C, D The axoneme is disorganized presenting a reduced number of microtubule 
doublets (arrow); the central pair complex is present (*). Images provided by Professor Mário Sousa. 
 
In patient 3 (Fig. 17), the TEM analysis show that the MP was small, with a few pale 
and disorganized mitochondria and that no An material was present. Like in the patient 
1, the PP was enlarged by the presence of hyperplastic and hypertrophic FS that 
invaded the MP. At the Ax level, absence of DA, nexin bridges and CPC, with presence 
of a variable number of RS were detected. 
 
Figure 17. Ultrastructure of sperm from Patient 3 A. Longitudinal section of the sperm showing an irregular nucleus 
(N) and a displaced acrosomal vesicle (AV). At midpiece (MP) the basal plate (BP), centriole (Ce), striated columns 
(SC) and outer dense fibres (ODF) show a typical structure. B. There was no visible annulus material (arrow) and is 
observed a hyperplastic and hypertrophic FS that invaded the MP; C.The axoneme shows absence of the central pair 
complex (*), a reduced number of radial spokes (black arrow), absence of dynein arms (blue arrows) and nexin bridges 
(dotted line). Images provided by Professor Mário Sousa. 
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In Patient 4 (Fig. 18), no An material was observed and the MP was invaded by 
a hyperplastic and hypertrophic FS. In the Ax, most of the sperm presented absence of 
the CPC and RS. Some sperm evidenced also total microtubule disorganization with an 
increased number of microtubule doublets and ODF.  
 
Figure 18. Ultrastructure of sperm from 
Patient 4 A. Longitudinal section of the 
sperm showing the head with a displaced 
acrosomal vesicle (AV). At midpiece (MP) 
the basal plate (BP), centriole (Ce), striated 
columns (SC) and outer dense fibres (ODF) 
show a typical structure. Also there was no 
visible annulus material (arrow) and is 
observed a hyperplastic and hypertrophic 
FS that invaded the MP; B. The axoneme 
showing absence of the central pair complex 
and radial spoke (*). C. A disorganized 
axoneme, with an increased number of 
microtubule doublets (small arrow) and ODF 
(large arrow). Images provided by Professor 
Mário Sousa. 
 
 
In patient 5 (Fig. 19), the MP was short and enlarged due to the presence of 
aggregated and misaligned pale mitochondria. At the Ax, all sections showed absence 
of DA and nexin links, with presence of RS and CPC. Besides, this patient reported 
chronic respiratory complains, with nasal polyps, chronic sinusitis, rhinitis and 
bronchitis. He also presented a situs inversus totalis. Therefore this patient present 
clinical feature compatible with Kartagener syndrome (KS), however, as the respiratory 
cells were not evaluated, cannot be affirmed that is a KS.    
 
Figure 19 Ultrastructure of sperm from Patient 5. A Shows an abnormal sperm head, with displaced acrosomal 
vesicle (AV). At midpiece (MP) the basal plate (BP), centriole (Ce), striated columns (SC) and outer dense fibres (ODF) 
show a typical structure. B. The annulus is present (arrow), and the MP is short and enlarged due to the presence of 
aggregated and misaligned pale mitochondria (m). At the principal piece the ODF and the FS have a normal 
appearance. C. The axoneme shows a conserved central pair complex (circle) and radial spokes (arrow); dynein arms 
(white arrowheads) and nexin bridges (dotted line) are missing. Images provided by Professor Mário Sousa.  
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ATTACHMENT 2 
This attachment contains the primers and amplification conditions that were 
used to sequence the following genes: AKAP3, AKAP4, CCDC39, CCDC40, DNAI1, 
DNAH5 and RSPH1. 
The standard primer design parameters were: primer length 18-25 bp; 
percentage of GC 40%-60%; amplicon length (AL) 400-650 bp; and Tm 59Cº-62Cº. 
Some primers have punctual modifications in the parameters, which are here referred. 
PCR conditions that were applied to each gene regions:  
1) Stand-38c, with an initial denaturation at 95°C for 2 min, followed by thirty-eight 
cycles of 95°C for 45 s, specific Ta (listed in tables below) for 30 s, and 72°C for 
1 min, with a final extension at 72°C for 10 min; 
2) Stand-35c, with an initial denaturation at 95°C for 10 min, followed by thirty-five 
cycles of 95°C for 1 min, specific Ta (listed in tables below) for 30 s, and 72°C 
for 2 min, with a final extension at 72°C for 10 min;  
3) High-GC, a PCR with an initial denaturation at 95°C for 5 min, followed by forty 
cycles of 95°C for 45 s, 58°C for 30 s, and 72°C for 1 min, with a final extension 
at 72°C for 10 min.  
4) Multi-Dmsc, a PCR with an initial denaturation at 95°C for 10 min, followed by 
thirty cycles of 95°C for 1 min, with a slower ramp reduction to 58/63°C for 30 s, 
and 72°C for 1 min, with a final extension at 72°C for 10 min;  
The standard PCR the reaction mixture (30 μl) contained: 15µl of PCR Master 
Mix [(Promega, Madison, USA) that includes 50 units/ml of Taq DNA polymerase 
supplied in a proprietary reaction buffer (pH 8.5), 400 µM dATPs, 400 µM dTTPs , 400 
µM dGTPs, 400 µM dCTPs and 3mM MgCl2]; 12 µl of sterile bidistilled water, 1 µl of 
each primer at 10 pmol/µl (Thermo Fisher Scientific, Einsteinstrasse, Germany) and 1 
µl of DNA at 100ng/µ).  
For the High-GC PCR condition, the reaction mixture (30 µl) contained: 12.5 µl 
of PCR Master Mix (Promega); 1.5 µl of sterile bidistilled water; 5 µl of Betaine 5M 
(Sigma-Aldrich, Missouri 63103, USA); 1,5 µl of DMSO (Bioline, London, United 
Kingdom), 1 µl of each primer at10 pmol/µl (Thermo Fisher Scientific) and 2,5 µl of 
DNA at 100ng/µl. 
To amplify some exons, the PCR Master Mix was replaced by either: i) 
EmeraldAmp Max HS PCR Master Mix (Takara Bio, Shiga, Japan), which includes a 
high yield, Hot Start (HS) PCR enzyme, gel loading dye (green) and a density reagent 
in a 2X Taq PCR Master Mix format; ii) ImmoMix™ Red (Bioline), which includes a 
heat-activated thermostable DNA polymerase and gel loading dye (red); and iii)  
DreamTaq Green PCR Master Mix 2X (Thermo Fisher Scientific). 
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Table1. List of primers used to amplify all the exonic regions of CCDC39 gene (NM_181426.1), 
including the respective modifications in primer design and the PCR conditions used.   
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Conditions/ 
PCR Mixture 
1 CTCAACCGGAAGTTTCGCC TGAAATAGGCAGAGAGGGTAAGGG 
 
Stand-38c;Ta=58ºC 
PCR MM 
2 AGCCTTCAGAACTGTGAGGAATTT CAGCCTAGGAAACAGAGCGAGA 
 
Stand-38c;Ta=58ºC 
PCR MM 
3 TTTCTTACAACTAGTGAGCAACACC CCATGTGCCTTTCACTGTCC 
Tm min: 55ºC; 
AL min: 300bp 
Stand-38c;Ta=58ºC 
PCR MM 
4 GCATATTATAAACATCTGGAAGGC GAAACAGTCAGCAATATTTTATGGG 
Tm min: 55ºC; 
GCs min: 35%; 
AL min:300bp 
Stand-38c;Ta=55ºC 
PCR MM 
5 ATTGAGTTTTTATGCAGCTATATGC CAATTCTAACTGTCAAACAGAGAGC 
Tm min: 55ºC; 
GCs min: 32%; 
Stand-38c;Ta=55ºC 
Emerald 
6 CTTACAGAGACTATAAGCGCACAGG ATCTACTGACTCTTTCTTGTTCCGC Tm min: 58ºC 
Stand-38c;Ta=55ºC 
PCR MM 
7.1 TCTACGACCAGTGAAAGGCC TGACATACCTCACCCTTCAGC 
Tm min: 56ºC; 
GCs min: 35% 
Stand-35c;Ta=63ºC 
Emerald 
7.2 CAAGTTTTTGGAAAGTGAGATTGG AATGAAAAGGTAACCTACAGAATGG 
Tm min: 56ºC; 
GCs min: 35% 
Stand-35c;Ta=63ºC 
Emerald 
8 GGTTAGAACTTAAAGTGGGCAGAA GATAGAAAACGTGCCTAAAAAGC 
no GC clamp; 
Tm min:56ºC; 
Stand-35c;Ta=63ºC 
PCR MM 
9 TTTTCATCACAAAGACTCAGAAGCC AGCAATGCATGAGAAGAGGTCC 
 
Stand-38c;Ta=58ºC 
PCR MM 
10 TGTATGACACGGGCGTAAAAGC CTGTCTGTCCTCCACAAAAGGG 
 
Stand-38c;Ta=58ºC 
PCR MM 
11 TGCCTAGTCCAAAGTCATAAGAAAG TCCTCACAAGACATCTGTAAGGATT  
Stand-38c;Ta=61ºC 
PCR MM 
12 TCCCCAGACAATACTGAGGG AAATTTCTTTACAAGACTGGAGGG 
Tm min: 56ºC; 
GCs min: 36%; 
Stand-38c;Ta=58ºC 
PCR MM 
13 ATGGCCATTCATAGGGCTT CAGCTAGTTCTCCTGACATCATC 
 
Stand-38c;Ta=58ºC 
PCR MM 
14 AGACACAATGAAACTGTGGCAGG CCTTTGTTAAGTGTAATAGTGGCCC Tm min: 56 ºC 
Stand-38c;Ta=58ºC 
PCR MM 
15 TTGAAGGCCTGATAATTTGGGC TCTTCCTCATGTCTCACAGTGTTCC 
 
Stand-38c;Ta=58ºC 
PCR MM 
16 AACAAGAAATGGCTACTACATGCCC ACTCTGAGCACTTGTTTTTGTCTCC 
 
Stand-38c;Ta=58ºC 
PCR MM 
17 CATATATACAGTCCATCATTGACCG AATAGATGAAGGAGGATTTGGG 
Tm min: 55ºC; 
AL min: 350bp 
Stand-38c;Ta=55ºC 
PCR MM 
18-19 AAATTAGAAAGAGTGACCAAACAGG GCGGTGATGTAGAAGTGGC 
Tm min: 55ºC; 
GCs min: 35%; 
Stand-38c;Ta=55ºC 
PCR MM 
20 TTTGCCAATAATGAGAGGGTC TGTAGCCTTGTCAAGAATCTGC 
 
Stand-38c;Ta=58ºC 
PCR MM 
Abbreviations: bp, base pair; CG min; minimal CG content; GC max, maximal GC content; Tm min, minimal temperature 
melting; Tm max, maximal temperature melting; AL min, minimal amplicon length; Ta, annealing temperature; MM, 
Master Mix; Emerald, EmeraldAmp Max HS PCR Master Mix; ImoMix, ImmoMix™ Red master mix.  
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Table 1. List of primers used to amplify all the exonic regions of CCDC40 gene (NM_ 
017950.3), including the respective modifications in primer design and the PCR conditions 
used. 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Conditions/ 
PCR Mixture 
1 GTGGAGATGGCACAAAGGCC GAGGACAAAGGGACAGGAGGG 
GCs max:64%; 
AL min: 350 bp 
High GC; 
PCR MM 
2 TTCATGGAGCTTTGCTTTTGTG CACAGTGCCCGTACTCTGATTC Tm min: 56ºC 
Stand38c; Ta=58ºC 
ImoMix 
3 ACAAGGTCCTTTATACTTTGTTTCC CCTTGCTAAGACATTTCTAACAGG  
Stand-38c;Ta=58ºC 
PCR MM 
4 ACTTCTCAGTGGCAATTAAGCCC GCGTTCTGTCACTTAATCGGACC  
Stand-38c;Ta=58ºC 
PCR MM 
5 GCAGCTGTGCCATTGATG GCATTTAGGGTCAGGAGTGGG  
Stand-38c;Ta=58ºC 
PCR MM 
6-7 GCAGGAGGGTAACCAGAAAGG CTGGCCATGGTACATGGAGAC  
Stand-38c;Ta=58ºC 
PCR MM 
8 CCAGGAGGATCTCTGAGACTTGG CTTCACGCAGGAGGCAAAGC  
Stand-38c;Ta=58ºC 
PCR MM 
9 GTGGCGTCAACTTGTATCAAGGG GCTAAGGAACTTGCTGAGCATCC  
Stand-38c;Ta=55ºC 
PCR MM 
10 CTTGAAAGCTACATTCAGGCTCG CTGAGCAGAAAAGCCTCTCCC  
Stand-38c;Ta=58ºC 
PCR MM 
11 TGGCTCTCTGATGTCTCACACG ATGGCAGCATCCGTCTTCC  
Stand-38c;Ta=58ºC 
PCR MM 
12 AGAAGCTCACCACCCAGTGC CAACCTGAACACCATGGAAAGG  
Stand-38c;Ta=58ºC 
PCR MM 
13 TCTGGGTTCCAACAAGTAGGTCC TAGGGAAAGAGGCAGTTCTGTGC  
Stand-38c;Ta=58ºC 
PCR MM 
14 AATTACAGGCGTGAGTCACTGC CATGCGCGTTTGTTATTTGC  
Stand-38c;Ta=55ºC 
PCR MM 
15 AGGAACGACAAGAGGGAGGG GCATCTTGAACGGGTGTGG  
Stand38c; Ta=58ºC 
ImoMix 
16 GACAGAGAATGAGTTCGTGCGC TGGTCTTCAACGGACAGAGGC  
Stand-38c;Ta=58ºC 
PCR MM 
17 AAACGTTTGCATAAGGAGCCC CCTGGAAATCTCACCCATTGC  
Stand-38c;Ta=58ºC 
PCR MM 
18 CTCCATGTCCCTTGTTCCTCC TGCAGTCTCCCAGACAGGC 
GCs max: 
64%; 
High GC; 
PCR MM 
19 CTGCTGAACTGTGCCAGTCTCC TGGTGCTATTACTGGCCTGGG  
Stand-38c;Ta=58ºC 
ImoMix 
20 CTTTTCAGGCGTAGGTCTCGC GTCACAGGCTCTGTCTTTGCG  
High GC; 
PCR MM 
Abbreviations: bp, base pair; CG min; minimal CG content; GC max, maximal GC content; Tm min, minimal temperature 
melting; Tm max, maximal temperature melting; AL min, minimal amplicon length; Ta, annealing temperature; MM, 
Master Mix; Emerald, EmeraldAmp Max HS PCR Master Mix; ImoMix, ImmoMix™ Red master mix.  
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Table 2. List of primers used to amplify all the exonic regions of DNAI1 gene 
(NM_001281428.1), including the respective modifications in primer design and the PCR 
conditions used. 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Conditions/ 
PCR Mixture 
1 TGGATTCTATCCTGCAAGGGC GGTAAGAAACGGTGGATTGGG  
Stand-38c;Ta=58ºC 
PCR MM 
2 CTCCTCAAATGCCACAAAGTG TTATAAGGTGGTAGGTTTAAGGGTG 
Tm min: 55ºC, 
CG min-35% 
Stand-38c;Ta=55ºC 
Emerald 
3_4 CAGGCAATGAGAACTCTGGCC TACTGAGAGGCTTTTGCAATGTAGC  
Stand-38c;Ta=58ºC 
PCR MM 
5 TTGAGGTTGGAAAGGCAAGG CAGAAGCTCTGAAAAGTTCTGGC  
Stand-38c;Ta=58ºC 
PCR MM 
6 AAAAAAGCCCAATAGCTGGTTG TCCTTTCCCAAGTTACCCATGA  
Stand-35c; Ta=61ºC 
PCR MM 
7 CCTCCCTGCCACAGATTGG AGGCTGAGGTCTGCTAGGGC 
Tm max:63ºC; 
GCs máx:65%; 
High GC; 
PCR MM 
8 CAGAATGGACACAATATGGGC CAGGGAGGCAAGTAGATGAGG 
AL min:380bp; 
Tm min- 58ºC, 
Multi-DMSC; 
Ta=63ºC Dream 
9 TTGAATACCTAATTCCAACAGGCC GGGAGGTATGGAATGCTAGAGGC  
Stand-38c;Ta=58ºC 
PCR MM 
10 CCCTTTGTGCCACTTGTGAGG GGGATTATTTTTTCTCCGCTTGC  
Stand-38c;Ta=58ºC 
PCR MM 
11 ATGGCCGGTGTATTGTAATGTACC CAAGGTGGTTAAGTGCAGAAGGG  
Stand-38c;Ta=58ºC 
PCR MM 
11_12 GGGTTTGCCATAAAGCGGC TCTTCCCCATTAGACTGTGAGCC  
Stand-38c;Ta=58ºC 
PCR MM 
13 CTTGATTGGTTGTTGGATCTTTCC ACCCAGATCCTGACCTGATGG  
Stand-38c;Ta=58ºC 
PCR MM 
14 TCTGCCCACAGCCCTAACTC ACTTCCGTGGTGCTGCCTT  
Stand-35c; Ta=61º 
PCR MM 
15 GGAGGCAGGGAGCTAAATGG TCTACAAACAGCCAAGGGTTCA  
Stand-35c; Ta=61º 
PCR MM 
16 GACCCTGTTTAACTCAATCCCTGC GCCCTTATTCCTATCACCCAAGC  
Stand-38c;Ta=58ºC 
PCR MM 
17_18 GCGATGTGGGTTAAGGACAGG TGAATGATTCCTCTTTTGGCTGG  
Stand-38c;Ta=58ºC 
PCR MM 
19 AAACACAGAGACACAAAATTCCCC TGGCTTCTCCCTTCTGTCATCC  
Stand-38c;Ta=58ºC 
PCR MM 
20 GGCAGGGATCCAGAATTTACTG GGGTGGGTTTCTACACAGGTTT  
Multi-DMSC; 
Ta=63ºC Dream 
Abbreviations: CG min, minimal CG content; GC max, maximal GC content; Tm min, minimal temperature melting; Tm 
max, maximal temperature melting; AL min, minimal amplicon length; Ta, annealing temperature; MM, Master Mix; 
Emerald, EmeraldAmp Max HS PCR Master Mix; Dream, DreamTaq Green PCR Master Mix 2X. 
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Table 3. List of primers used to amplify all the exonic regions of AKAP3 gene 
(NM_001278309.1), including the respective modifications in primer design and the PCR 
conditions used. 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Conditions/ 
PCR Mixture 
1 CCATCTTTTCCCACAATCCCC GCTCGACGCACATTTATTTACTTGG  
Stand-38c;Ta=58ºC 
PCR MM 
2 CCCTGGTGTGAAAAAGTTTGGG CAGCTGGACAGAAGAACAACGC  
Stand-38c;Ta=58ºC 
PCR MM 
3 ACCTTTTTGTCATCTTGGAACTGC CAAAGAATTGGAAGACTTGGAAGC  
Stand-38c;Ta=58ºC 
PCR MM 
4 ATTCCTTCCATTGAGAGCTGAGG TTTGTTCTATAAGGGCTGATTTCCC  
Stand-38c;Ta=58ºC 
PCR MM 
5(.1.1) TGAGAGGGCTGATGACATTTGT TGACTAGATTCGTGAGGCGGTT  
Stand-35c;Ta=58ºC 
PCR MM 
5(.1.2) GGGAAACGTCCAACTCAGGAG CATTCCTGGAACATGCAGAGAC  
Stand-35c;Ta=58ºC 
PCR MM 
5(.2) GGGAGTTCAGTAGATGAAGTTTCC CAATGGTTGTGTCTTTCACTTGG Tm -57ºC 
Stand-38c;Ta=58ºC 
PCR MM 
5(.3) AAAGAGGTTTCGAGGGCAGG GGCTTACGCTGTGTGTTGGG  
Stand-38c;Ta=58ºC 
PCR MM 
5(.4) GGGTGAGCACATTATCAAAGAGGG CAACGGTCTTTCACACAACTTCC  
Stand-38c;Ta=58ºC 
PCR MM 
5(.5) GTAGCTCCCGATGAATCTTGCC ACTTGTCATCTCCCAGCTCTGCC  
Stand-38c;Ta=58ºC 
PCR MM 
5(.6) GCTGTGTGTCATCATTGCTAAGTCC GATCTTCAAATCCCACTGTTCCC  
Stand-38c;Ta=58ºC 
PCR MM 
6 GGGAAACGTCCAACTCAGGAG CATTCCTGGAACATGCAGAGAC  
Stand35c;Ta=61ºC; 
Emerald 
Abbreviations: Tm min, minimal temperature melting; Ta, annealing temperature; MM, Master Mix; Emerald, 
EmeraldAmp Max HS PCR Master Mix.  
 
Table 4. List of primers used to amplify all the exonic regions of AKAP4 gene (NM_003886.2), 
including the respective modifications in primer design and the PCR conditions used. 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Conditions/ 
PCR Mixture 
1 TTAGAGCCCTCCATCTTTGTGC TTCATTTCCTGCGAGACCTCC  
Stand-38c;Ta=58ºC; 
PCR MM 
2 CCCACCAGTTCCTAGCCTAAACC TTACATCACACCACACCCTGCC  
Stand-38c;Ta=58ºC; 
PCR MM 
3 TGCTAATGCTAAGATTCTGTCTGCC TTCAGAACCAGGGATCTTGGG  
Stand-38c;Ta=58ºC; 
PCR MM 
4 TTTGTGAGCATCTTCAGAGTGGG TCTTACCATGTCTGATCCAGAGTCC  
Stand-38c;Ta=58ºC; 
PCR MM 
5.1 CAAACTCCAAAAGGTCAAATCCC TTCTCCTTGATTTCCTTATGGGC  
Stand-38c;Ta=58ºC; 
PCR MM 
5.2 TCAGCTCCTCCAGCCAAACC CAATCAAATCGGACACAATCTCC  
Stand-38c;Ta=58ºC; 
PCR MM 
5.3 AATTCCAGCATCTGTGGTCC GCCAGTGAATCTGTGGAAGC  
Stand-38c;Ta=58ºC; 
PCR MM 
5.4 CACATTCTCAAAGAGGGCCTAACC AATTGCCCGTTCGCTTGC  
Stand-38c;Ta=58ºC; 
PCR MM 
5.5 AGCAAAGCAGCTTCCATGTCC TGAAACTCGAATGATCTTGGGC  
Stand-38c;Ta=58ºC; 
PCR MM 
6 AGATGTGTCAGCAGCCTCTAGTCC CCAACACTGTATCACCATTCCTGG  
Stand-38c;Ta=58ºC; 
PCR MM 
Abbreviations: Ta, annealing temperature; MM, Master Mix. 
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Table 5. List of primers used to amplify 40 (of a total of 79) exons of DNAH5 gene 
(NM_001369.2), and the respective modifications in primer design and PCR conditions used. 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Condition/ 
PCR Mixture 
3 TCAACAGCTCAACACTTTAGGG CAGGTCCGTTCTCACAGTAGC Tm min-56ºC 
Stand-35c; Ta=55ºC 
PCR MM 
6 GGCTTTGGGTTGAATTGTGAGG TGACAGTAAAGGAAAACCACATTGG  
Stand-35c; Ta=61ºC 
PCR MM 
7 ATTGGAAGCATGGAATACGC AGCCTCCAAAGTGATGTGAGG Tm min-56ºC 
Stand-35c; Ta=58ºC 
PCR MM 
8 AGGTCTCGCCTAATGGACTTG CAATTCAGCTAGTGCAAAAAGG  
Multi-DMSC; 
Ta=58ºC; PCR MM 
9 TTAATGCAGATGGAATGGTTAGTC CATAGGAAAGAAATTCCAAGAGC Tm min-55C 
Stand-35c; Ta=55ºC 
PCR MM 
11 AATTTTGCTGTCGCCTTCAC AGCACCATTACACAATTCTCAAAC 
Tm min-56ºC; 
CGs min- 36%,  
GC clamp:1 
residue 
Stand-35c; Ta=55ºC 
PCR MM 
12 TGATTTCTTTGAATGCAGTAGGGC AATCATTGCTACACAGTGACAAACG  
Stand-35c; Ta=58ºC 
PCR MM 
13 AGTACCCGTGGAACCTGACG TGACCCAAATTGCCAAGAGAG 
Tm min-56ºC; 
CGs min- 36%, 
GC clamp:1 
residue 
Stand-35c; Ta=55ºC 
PCR MM 
14 TGTCTTCCCAAGTTAATAGTTTTGC GCTTAGATTCAACCCATCTGCC 
Tm min-56ºC; 
CGs min- 36% 
Stand-35c; Ta=55ºC 
Emerald 
17 GGATATTTTATTAGCGACAACCAAG TGATCTGAAATGATGTGTTCCC 
Tm min-56ºC; 
CGs min- 36%, 
GC clamp:1 
residue 
Stand-35c; Ta=55ºC 
Emerald 
25 GCACAGTTAACCTCTTGCGG AGGAAGTTTCACAGAAATTTACCC  
Stand-35c; 
Ta=61ºC; PCR MM 
27 CATCTCTGGCTTGCTTGTTTGC CAATGGACAAGAACAATGCAGC  
Stand-35c; Ta=61ºC 
PCR MM 
28 AAATACTAGCAGACCGTCTTGGTCC GCAGAATCTGTCCCATCTTAGGC  
Stand-35c; Ta=61ºC 
PCR MM 
30 AAATAGGCACAGAAGCTCAGTAGGG GACAACAAAAAGATTGAAGGAAGGG  
Stand-35c; Ta=61ºC 
PCR MM 
31 GATGATATGGCACAGAAAGCCC CAGTGATGGAAGCAACCTTAAGTCC  
Stand-35c; Ta=61ºC 
PCR MM 
32 CTCCCCTTTTCCCATCCAGG CAGTTCTGAAGGTAAATTGGGCC  
Stand-35c; Ta=61ºC 
PCR MM 
33 TTACTTTCTTTGGGAAGGACAAG AGATTGATTAGGGAAAAAACCG 
Tm min-55ºC; 
CGs min- 35%, 
GC clamp:1 
residue 
Stand-35c; Ta=58ºC 
PCR MM 
34 AATACAGGAAACAATGAGAAACGTG TTCTACTGGGTAAATGCAGATAGTG 
Tm min-55ºC; 
CGs min- 36%, 
GC clamp:1 
residue 
Stand-35c; Ta=58ºC 
PCR MM 
35 TGAATAGCTTGGCTGGTGATACAG AGGCAAAGGAAGCAAGGTCTG 
gc clamp: 
1residue 
Stand-35c; Ta=61ºC 
PCR MM 
Abbreviations: CG min, minimal CG content; GC max, maximal GC content; Tm min, minimal temperature melting; Tm 
max, maximal temperature melting; AL min, minimal amplicon length; Ta, annealing temperature; MM, Master Mix; 
Emerald- EmeraldAmp Max HS PCR Master Mix; ImoMix, ImmoMix™ Red master mix; Dream, DreamTaq Green PCR 
Master Mix 2X. 
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Table 5. (continuation) 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Condition/ 
PCR Mixture 
36 ATCTTGTGTGCGTTTCATGCC GCATCAAGTGACCCAAAACAGC  
Stand-35c; Ta=61ºC 
PCR MM 
41 GGCCATCATTGTTGTGTTTCAA CCTCTTGGGCATTCAAATGGG  
Stand-35c; Ta=61ºC 
PCR MM 
43 CAAGGTGCTCAATGAATATTTGTCC GGGTTTGAATGTCCCAGTGC  
Stand-35c; Ta=61ºC 
PCR MM 
44 AGGCTACCTACACTTCCTGGGC TATTCCCCCTCCCCAACAGC  
Stand-35c; Ta=61ºC 
PCR MM 
45 CCTATTATGTTTAAAGGCAGCTTGC CGAACGTTTTCATATCTTACAGCC  
Stand-35c; Ta=61ºC 
PCR MM 
48 TTCATATCAGTTCAAAGGTTACCAG CTAACTCCTTGAGTGTTTCCAAAG 
Tm min- 55ºC; 
CGs min- 35%, 
Stand-35c; Ta=58ºC 
PCR MM 
49 TCAAGGAGTTAGGCTCCGGG TCCAGACCTCAAAACTATGTGCC  
Stand-35c; Ta=61ºC 
PCR MM 
50 TGGTGCAACCAGAGTCTTCG AAAGCAGTAAAGAATACCCATGC  
Stand-35c; Ta=61ºC 
PCR MM 
51 CTGTCAACCTGAATTCCCAATTACG TCTCCTACCGAATCCTGCCC  
Stand-35c; Ta=61ºC 
PCR MM 
53 CATTCCTTCAACCAGTGTGTCTC TATAACATAAAAGTAGGGAGGTGGC 
Tm min- 56ºC; 
GC clamp:1 
residue 
Stand-35c; Ta=58ºC 
PCR MM 
54 ATAACAGGGCATCTCACTCACCC ATCCCCAATAGCACTTATTCACACC  
Stand-35c; Ta=61ºC 
PCR MM 
60 TGGTCGTTCAGTAGTTTCAGTGGC TCTATGCTCACTCTCCCCATG  
Stand-35c; Ta=61ºC 
PCR MM 
61 ATTTTGATTTTGCCTCTTGGCC CAGCCATCTTGACTGACCATCC  
Stand-35c; Ta=61ºC 
PCR MM 
63 CTGTACAATCACACGGATGAACG CCTGGACCCTGACAGAATAGCC  
Stand-35c; Ta=61ºC 
PCR MM 
67 TGTATCCCGTATCTGGTAGGCAGC AGGGCATCATCACTCACAACG Tm max- 63ºC 
Stand-35c; Ta=61ºC 
PCR MM 
68 AGATATCGTTGTGAGTGATGATGCC TTCCATGCCCAGGTATACAGTAGG  
Stand-35c; Ta=61ºC 
PCR MM 
72 
 
GTGTATACTGGAACAAATGCATGG GAGCTCTGATTCTTTCACACTGC 
Tm min- 55ºC;  
GC min- 35% 
Stand-35c; 
Ta=58ºC;PCR MM 
73 TCTTGTTAGATTGGCAGGAAGTTG ACGCCAAAGCTAGGAGGTCC Tm min-57ºC 
Stand-35c; Ta=61ºC 
PCR MM 
75 AATTTAGACGGTGCTTATGTTGGC GGAAGGTTCAGAAAAGCAGTCC  
Stand-35c; Ta=58ºC 
Emerald 
76 TTATGGAATAGTAAGAATTTGGGCCT GGCTTCGTCCCTGTGCAA  
Stand-35c; Ta=61ºC 
PCR MM 
77 TTGAAACACTTACGCCAGAATC AGCTAGCAGCCTGAGAACAAC  
Stand-35c; 
Ta=58ºC PCR MM 
Abbreviations: bp, base pair; CG min, minimal CG content; GC max, maximal GC content; Tm min, minimal temperature 
melting; Tm max, maximal temperature melting; AL min, minimal amplicon length; Ta, annealing temperature; MM, 
Master Mix. 
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Table 6. List of primers used to amplify all the exonic regions of RSPH1 gene (NM_080860.3), 
including the respective modifications in primer design and the PCR conditions used. 
 
 
 
Abbreviations: Tm min, minimal temperature melting; Ta, annealing temperature; MM, Master Mix. 
Exon Primer Forward Primer Reverse 
Changes in 
Primer design 
Parameters 
PCR Condition/  
PCR Mixture 
1 CTATGACAGTACGCAAAGGCTGC CCTCGATGGGAATTAACACAGG  
Stand-35c; Ta=58ºC 
PCR MM 
2 ATGAATTGCAAGCTCTGTGTTGG TGTAGATCCCCTGAAACACATTG Tm min: 58ªC 
Stand-35c; Ta=58ºC 
PCR MM 
3 CAGAACCGTTGACTTGACTGGATG GGCCACAGGGACAGATTTCC  
Stand-35c; Ta=58ºC 
PCR MM 
4 TCTTAGCCCACTGTCCACCG TGAAAGACTCACGTGCTCTGCC Tm min: 58ªC 
Stand-35c; Ta=58ºC 
PCR MM 
5 TTGTGAGCCTGCAACAGCC TGTACTGAGATCCAGAGAAACGGG  
Stand-35c; Ta=58ºC 
PCR MM 
6 TCCAATCCCATCAGCCACG GGGAAATGATATTGTTTGCTTCTGG  
Stand-35c; Ta=58ºC 
PCR MM 
7 GTCTTTCAAAACTTGTCCTTCCTCC AAAACAGGATGTCCACAACTCCC  
Stand-35c; Ta=58ºC 
PCR MM 
8 ATCAACACCCTCAGGAATGAAAG GCAACGTTCTGAGATGGCTCC Tm min: 58ªC 
Stand-35c; Ta=58ºC 
PCR MM 
9 CGTATTTTGCTTATTTTATGTCGGG CCACTCACTGCAACTGCCAC Tm min: 57ªC 
Stand-35c; Ta=58ºC 
PCR MM 
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ATTACHMENT 3 
 
In this supplementary information 67 candidate genes selected based on the literature 
and used for exome analysis are a listed.  
 
Gene Symbol Gene full name Locus 
ACVR2B Activin A receptor, type IIB 3p22 
ARMC4 Armadillo repeat containing 4 10p12.1-p11.23 
C21orf59 Chromosome 21 open reading frame 59 21q22.1 
CATSPER1 Cation channel, sperm associated 1 11q12.1 
CATSPER2 Cation channel, sperm associated 2 15q15.3 
CCDC103 Coiled-coil domain containing 103 17q21.31 
CCDC114 Coiled-coil domain containing 114 19q13.33 
CCDC65 Coiled-coil domain containing 65 12q13.12 
CFC1 Cripto, FRL-1, cryptic family 1 2q21.1 
CRISP2 Cysteine-rich secretory protein 2 6p12.3 
DNAAF1 Dynein, axonemal, assembly factor 1 16q24.1 
DNAAF2 Dynein, axonemal, assembly factor 2 14q21.3 
DNAAF3 Dynein, axonemal, assembly factor 3 19q13.4 
DNAH1 Dynein, axonemal, heavy chain 1 3p21.1 
DNAH10 Dynein, axonemal, heavy chain 10 12q24.31 
DNAH11 Dynein, axonemal, heavy chain 11 7p21 
DNAH12 Dynein, axonemal, heavy chain 12 3p14.3 
DNAH14 Dynein, axonemal, heavy chain 14 1q42.12 
DNAH17 Dynein, axonemal, heavy chain 17 17q25.3 
DNAH2 Dynein, axonemal, heavy chain 2 17p13.1 
DNAH3 Dynein, axonemal, heavy chain 3 16p12.3 
DNAH5 Dynein, axonemal, heavy chain 5 5p15.2 
DNAH6 Dynein, axonemal, heavy chain 6 2p11.2 
DNAH7 Dynein, axonemal, heavy chain 7 2q32.3 
DNAH8 Dynein, axonemal, heavy chain 8 6p21.2 
DNAH9 Dynein, axonemal, heavy chain 9 17p12 
DNAI2 Dynein, axonemal, intermediate chain 2 17q25 
DNAL1 Dynein, axonemal, light chain 1 14q24.3 
DPCD Deleted in primary ciliary dyskinesia 10q24.32 
DRC1 Dynein regulatory complex subunit 1 2p23.3 
DYX1C1 Dyslexia susceptibility 1 candidate 1 15q21.3 
FOXJ1 Forkhead box J1 17q25.1 
FSIP1 Fibrous sheath interacting protein 1 15q14 
FSIP2 Fibrous sheath interacting protein 2 2q32.1 
GAPDHS 
Glyceraldehyde-3-phosphate dehydrogenase, 
spermatogenic 
19q13.12 
GAS8 Growth arrest-specific 8 16q24.3 
HEATR2 HEAT repeat containing 2 7p22.3 
HYDIN HYDIN, axonemal central pair apparatus protein 16q22.2 
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Gene Symbol Gene full name Locus 
INVS Inversin 9q31 
KIF3A Kinesin family member 3A 5q31 
KIFC1 Kinesin family member C1 6p21.3 
LEFTY2 Left-right determination factor 2 1q42.1 
LRRC6 Leucine rich repeat containing 6 8q24.22 
NME8 NME/NM23 family member 8 7p14.1 
ODF1 Outer dense fiber of sperm tails 1 8q22.3 
ODF2 Outer dense fiber of sperm tails 2 9q34.11 
ODF3 Outer dense fiber of sperm tails 3 11p15.5 
ODF4 Outer dense fiber of sperm tails 4 17p13.1 
OFD1 Oral-facial-digital syndrome 1 Xp22 
RHPN1 Rhophilin, Rho gtpase binding protein 1 8q24.3 
ROPN1 Rhophilin associated tail protein 1 3q21.1 
ROPN1L Rhophilin associated tail protein 1-like 5p15.2 
RPGR Retinitis pigmentosa gtpase regulator Xp21.1 
RSPH4A Radial spoke head 4 homolog A 6q22.1 
RSPH9 Radial spoke head 9 homolog 6p21.1 
SEPT12 Septin 12 16p13.3 
SEPT4 Septin 4 17q22 
SEPT7 Septin 7 7p14.2 
SPAG1 Sperm associated antigen 1 8q22.2 
SPAG16 Sperm associated antigen 16 2q34 
SPAG17 Sperm associated antigen 17 1p12 
SPAG4 Sperm associated antigen 4 20q11.21 
SPAG5 Sperm associated antigen 5 17q11.2 
TCTE3 T-complex-associated-testis-expressed 3 6q27 
TEKT2 Tektin 2 (testicular) 1p34.3 
ZIC3 Zic family member 3 Xq26.2 
ZMYND10 Zinc finger, MYND-type containing 10 3p21.3 
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ATTACHMENT 4 
 
This attachment contains the primers’ sequences and PCR amplification 
conditions used to confirm, the candidate variants selected from the whole exome 
sequencing of the patient compatible with Kartagener syndrome. 
 
The selected genes for Sanger sequencing confirmation were: CCDC103 
(NM_001258398), DNAH10 (NM_207437.3), DNAH6 (NM_001370.1), GAS8 
(NM_001481.2), SPAG17 (NM_206996.2), INSL6 (NM_007179.2), MYCBPAP 
(NM_032133.4).  
The primers’ standard design parameters were: primer length 18-25 bp; 
percentage of GC 40%-60%; amplicon length (AL) 400-650 bp; and Tm 59Cº-62Cº. 
Some primers have slight modifications in the parameters, which are also referred in 
this supplementary data.  
 
Two PCR conditions were used: 1) Stand-35c, with an initial denaturation at 
95°C for 10 min, followed by thirty-five cycles of 95°C for 1 min, 58º for 30 s, and 72°C 
for 2 min, with a final extension at 72°C for 10 min; and  2) High-GC, a PCR with an 
initial denaturation at 95°C for 5 min, followed by forty cycles of 95°C for 45 s, 63°C for 
45 s, and 72°C for 1 min, with a final extension at 72°C for 10 min.  
The  Stand-35c reaction mixture  (30 μl) contained: 15µl of PCR Master Mix 
[(Promega, Madison, USA) that includes 50 units/ml of Taq DNA polymerase supplied 
in a proprietary reaction buffer (pH 8.5), 400 µM dATPs, 400 µM dTTPs, 400 µM 
dGTPs,  400 µM dCTPs and 3mM MgCl2];  12 µl of sterile bidistilled water, 1 µl of each 
primer at 10 pmol/µl (Thermo Fisher Scientific, Einsteinstrasse, Germany) and 1 µl of 
DNA at 100ng/µl.  
For the High-GC PCR condition, the reaction mixture (30µl) contained: 12.5 µl 
of DreamTaq Green PCR Master Mix 2x (Thermo Fisher Scientific); 1.5 µl of sterile 
bidistilled water; 5 µl of Betaine 5M (Sigma-Aldrich, Missouri 63103, USA); 1.5 µl of 
DMSO (Bioline, London, United Kingdom), 1 µl of each primer at 10 pmol/µl (Thermo 
Fisher Scientific) and 2.5 µl of DNA at 100ng/µl. 
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Table 7. List of the primers and PCR conditions used to validate the variants identified 
through the whole exome sequencing analysis. 
Gene Exon 
Primer Forward (F) 
Primer Reverse (R) 
Changes in 
Primer design 
Parameters 
PCR Condition/ 
PCR Mixture 
CCDC103 2 
F: AATGCCTCCTCGACTGAAGC 
R: AAGATCAAACAGTAGACGGTGGG 
GC min:35% 
 
Stand-35c;Ta=58ºC 
PCR MM 
DNAH10 47 
F:TCCATTGTACGGCTCTGCC 
R: CACATCCTATAACCAACCGGC 
Tm min:58ºC; 
GC min: 37% 
Stand-35c;Ta=58ºC 
PCR MM 
DNAH6 20 
F:GAGAGCAATAAGGAGGAAAATGGGA 
R: ACTGGTCTAGGGAAAATGCTCTG 
 
Stand-35c;Ta=58ºC 
PCR MM 
GAS8 7 
F: CTGCGACAGGTGGATAGGTG 
R: AGGAGAACACGAGGCAGAGA 
 
Stand-35c;Ta=58ºC 
PCR MM 
SPAG17 31 
F: AAGAACAGCAGGCCACACTCC 
R: TGGCATGGGATGTAAAAAGGG 
 
Stand-35c;Ta=58ºC 
PCR MM 
INSL6 1 
F: CGCAGACAGGGAGCAGGGT 
R: GAGCTGTGTACTAGGCACAAATTCC 
Tm máx:64ºC; 
GC máx:70% 
High GC; Ta=63º; 
Dream 
MYCBPAP 1 
F: CCGCAGGGCTTTCTAGGG 
R: AGTGCGCTGTAGGCTCTTCCT 
Tm máx:60ºC; 
GC máx:67%; 
High GC; Ta=63º; 
Dream 
 
Abbreviations: F, forward primer; R, reverse primer; CG min, minimal CG content; GC max, maximal GC content; Tm 
min, minimal melting temperature; Tm max, maximal melting temperature; Ta, annealing temperature; PCR MM, PCR 
Master Mix (Promega); Dream, DreamTaq Green PCR Master Mix 2X (Thermo Fisher Scientific).   
 
